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SIRS  Systemic inflammatory response syndrome 
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DEFINITIONS 
 
Primary or early intramedullary nailing is defined as fracture stabilization within 24 hours 
after the initial trauma. 
A prethrombotic state is characterized by an imbalance of hemostasis with a tendency to 
hypercoagulability without signs of thrombosis or evidence of fibrinogen or platelet 
consumption or fibrin deposition1,2. 
Systemic inflammatory response syndrome (SIRS)           
The criteria for SIRS were established in 1992 as part of the American College of Chest 
Physicians/Society of Critical Care Medicine Consensus Conference3. The conference 
concluded that the manifestations of SIRS include, but are not limited to, systemic 
inflammation caused by microorganisms and can thus be diagnosed in the absence of 
infection when two or more of the following criteria are present: 
 Body temperature less than 36°C or greater than 38°C 
 Heart rate greater than 90 beats per minute 
 Tachypnoea with respiration rate greater than 20 breaths per minute, or partial pressure 
of arterial oxygen (PaCO2) less than 4.3 kPa 
 White blood cell count less than 4 x 109 cells/L or greater than 12 x 109 cells/L, or the 
presence of greater than 10% immature neutrophils 
Severely injured patients                
The degree of severity of injury was categorized according to the Injury Severity Score (ISS) 
based on the Abbreviated Injury Scale (AIS)4,5.  The patients were defined severely injured 
when ISS ≥ 166,7. 
Acute lung injury (ALI)/Adult respiratory distress syndrome (ARDS)                  
The current clinical standard for the diagnosis of ALI/ARDS in accordance with the 1994 
American-European Consensus Criteria8 was used. The diagnosis rests on: 
 Acute onset 
 Bilateral infiltrates on antero-posterior chest radiographs 
 A low ratio of partial pressure of arterial oxygen to the fraction of inhaled oxygen 
(PaO2/FiO2); for ALI PaO2/FiO2 less than 40 kPa (300 mmHg) and for ARDS PaO2/FiO2 less 
than 27 kPa (200 mmHg) 
 The absence of clinical evidence of left atrial hypertension 
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Sepsis             
Sepsis is defined as infection plus systemic manifestations of infection9. The systemic 
response is manifested by two or more of the following conditions as a result of infection3. 
 Body temperature less than 36°C or greater than 38°C 
 Heart rate greater than 90 beats per minute 
 Tachypnoea with respiration rate greater than 20 breaths per minute, or PaCO2 less than 
4.3 kPa 
 White blood cell count less than 4 x 109 cells/L or greater than 12 x 109 cells/L, or the 
presence of greater than 10% immature neutrophils 
Pneumonia              
Pneumonia is a disease marked by inflammation of the lungs and caused by viruses, bacteria, 
or other microorganisms. Pneumonia was diagnosed when the body temperature was 
greater than 38.5°C and if, in addition, one of the following criteria was met: infiltration on 
chest radiographs in the absence of ARDS or positive bacterial culture in bronchoalveolar 
lavage fluid. 
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SUMMARY 
Background: An important part of the early trauma management is stabilization of long bone 
fractures. The intramedullary reaming and nailing of femoral shaft fractures has, however, 
been associated with pulmonary complications. These are probably due to the intravasation 
of bone marrow content as a result of the procedure-related increased intramedullary 
pressure (IMP). In order to reduce the complications, alternative systems that reduce IMP 
during reaming have been developed. One focus has been techniques using suction and 
irrigation during reaming. We wanted to evaluate the effect of using a one-step Reamer-
Irrigator-Aspirator (RIA) system and compare it to a traditional reaming (TR) system, with the 
hypothesis that the RIA system represents a lesser operative burden than the TR system. 
Additionally, we wanted to evaluate to what extent cardiopulmonary function and 
inflammation becomes further affected by femoral intramedullary nailing (IMN) in severely 
injured patients, with the hypothesis that the burden of the procedure to a certain extent 
will drown in the massive response to the initial trauma.  
Materials and Methods: In an experimental model including 28 Norwegian landrace pigs the 
IMP (Paper I), cardiopulmonary alterations (Paper II), numbers of lung embolisms (PE) (Paper 
II), inflammatory response (Paper III) and the associations between these (Paper IV) were 
studied during IMN and the first three post procedure days. The animals were divided into 
three groups, and the left intact femur was operated on either by the use of a traditional 
reaming (TR) system, a RIA system, or the animals were exposed to a sham operation. In 12 
polytraumatized patients with femoral shaft fractures primarily intramedullary stabilized, we 
investigated prospectively to what extent the cardiopulmonary and inflammatory response 
was further activated related to reamed IMN (Paper V). The patients were followed for three 
days after IMN. In the postoperative course the following complications were recorded: 
SIRS, ALI, ARDS, pneumonia, sepsis and local wound infection.  
Results: The IMP (Paper I), the numbers of PE (Paper II) and the procedure-related 
inflammatory response (Paper III) were reduced after RIA reaming compared to reaming 
with the TR device. Both reaming devices induced a hemodynamic procedure-related effect, 
but with no significant difference between reaming with the RIA system and reaming with a 
TR system (Paper II). The lowering of IMP, as obtained with the RIA system, reduced the 
magnitude and the effects of the bone marrow intravasation (Paper IV).                               
In the severely traumatized patients (Paper V) no additional procedure-related coagulation- 
and fibrinolytic response was found. Increased levels of TNF-α, IL-6 and IL-10, however, were 
found, and a transient (ns) procedure-related hemodynamic response was observed. All 
patients except one fulfilled the criteria of SIRS. The postoperative course was prolonged by 
pneumonia (7/12), ALI (3/12), ARDS (3/12) and sepsis (3/12). All the patients had additional 
extremity- and chest injuries. 
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Discussion: In healthy human individuals the amount of pulmonary vessels occluded needed 
to cause hemodynamic alterations has been estimated to be as high as 30 - 50%. In our 
experimental model the animals were young and healthy, and the embolic load induced by 
the procedure was probably not sufficiently massive to cause marked alterations. 
Additionally, the length of the pig femur is relative to body size about 50% shorter than in 
humans, resulting in a smaller potential volume of bone marrow content that can be 
extruded into the vascular system of the pigs. In our experimental model the response to 
reaming with the RIA and the TR systems per se were isolated and thoroughly investigated. 
In clinical practice, however, femoral shaft fractures are often caused by injuries involving 
high energy and are therefore associated with multiple and severe injuries. Severely injured 
patients already have an activated inflammatory system at hospital admission. The 
procedure-related hemodynamic response seen in the severely injured patients can be 
interpreted as a response to an embolic load, which may also contribute to the increased 
inflammatory response. The patients in this study had a high complications rate; the 
complications on which we focused were related to an increased inflammatory response.  
Conclusions: Overall, in this work on reamed IMN on intact pig femora without any 
additional injuries or confounding artifacts, the RIA system seems to represent a reaming 
method with a lower operative burden than the TR system. The harmful effects of reamed 
IMN in severely injured patients, however, are difficult to pinpoint. 
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INTRODUCTION 
EVOLUTION IN ORTHOPEDIC TRAUMA TREATMENT 
Until the 1970s, initial treatment of fractures in polytraumatized patients was conservative, 
as the patients were considered physiological unstable and the operative treatment 
regarded as a high-risk procedure. The fear of complications related to fracture manipulation 
with intravasation of bone marrow content10,11 led to delayed operative treatment and long 
time immobilization of the polytraumatized patients, which again resulted in high incidence 
of complications, mainly related to immobilization, like pneumonia, respiratory 
complications, pulmonary embolism, thrombembolisms and decubitus12,13.  Several 
publications in the 1970s, however, changed the treatment strategy of the polytraumatized 
patients dramatically14-17. Early operative treatment of long bone fractures in severely 
injured patients was demonstrated to decrease mortality and morbidity, in particular the 
pulmonary related morbidity12,18,19. The theory of the severely injured patient being too 
weak to be treated operatively was replaced by the theory of the severely injured patient 
being too weak to be treated non-operatively. The principle of “early total care” was 
established. A modification of the principle of “early total care” was allocated in severely 
injured, hemodynamically instable patients, who were not expected to tolerate the extent of 
surgery caused by internal major fracture stabilization. In these patients the concept of 
“damage control orthopedics”20 was applied; initial bleeding control, hemodynamical 
stabilization, and external fixation of major instable fractures, with secondary internal 
fracture stabilization in a stable situation. Pape et al.21 concluded in a study that early IMN, if 
performed in “borderline patients”, which are patients with severe trauma and associated 
pulmonary injury, increased the risk of pulmonary injury and the development of ARDS21. In 
several trauma centers, the strategy of “damage control orthopedics” was therefore also 
applied in “borderline patients”. The results from a study of Morshed et al.22 from 2009 
supported a moderate delay of definitive treatment of long-bone injuries in patients with 
multisystem trauma also as a means of damage-control orthopedics in order to reduce 
adverse outcomes. Today, femoral IMN should be performed as early as possible in the well 
resuscitated patient.  
 
POLYTRAUMA AND FEMORAL SHAFT FRACTURES  
The appropriate timing of internal fracture stabilization has been and still seems to be 
controversial23-27. Early IMN of femoral shaft fractures (earlier than 24 hours post injury) has 
in some studies been associated with reduced pulmonary complications and mortality16,18,28-
30, whereas in other studies early IMN has been associated with increased inflammation, 
multi organ failure (MOF) and morbidity31-34. In patients with severe chest trauma Pape et 
al.21 found a higher incidence of posttraumatic ARDS and mortality when early femoral IMN 
was done. In the study of Morshed et al.22, the authors focused on the effect of treatment 
with internal fixation of femoral shaft fractures in patients they described to be in an “under-
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resuscitated” state. They concluded that delayed internal fixation of femoral shaft fractures 
beyond twelve hours post hospital admission, which allow time for appropriate resuscitation 
in severely injured patients, reduces mortality by approximately 50%. According to the 
current literature severely injured patients with femoral shaft fractures should be treated 
with internal femoral stabilization when properly resuscitated and well perfused22. 
  
SUCTION-IRRIGATION-REAMING (RIA) 
The main thoughts behind the development of the RIA system are:  
1) reduced complications due to reduced intravasation of bone marrow content and  
2) increased bone healing through medullary fat removal 
Intramedullary nailing of femoral shaft fractures was introduced by Küntscher in 193935,36, 
and he was also the first to express his concerns considering events related to 
intramedullary procedures37. In the 1950’s, however, the complications related to medullary 
content intravasation increased as Küntscher introduced motorized reaming which enabled 
the introduction of larger diameter nails to improve the fracture stability and reduce the 
hardware failure. With the hypothesis that the intramedullary fat had a negative influence 
on bone healing, Dankwardt-Lillieström et al.38,39 performed in 1970 a randomized 
experimental study in rabbits comparing reaming after removing of medullary content with 
reaming of the bone with the medullary content left in situ. No medullo-hematomas were 
seen in the suction group where reaming was accomplished with negative pressure in front 
of the reamer head. The suction group had no local infections or deaths, whereas the no 
suction group had two deaths from infection and four deaths from massive fat embolization 
(11%). In these studies increased bone healing and bone vascularity was seen after reaming 
with suction compared to reaming without suction. The reduction of bone marrow fat was 
assumed to be the reason for the improved bone healing. The investigation of the suction-
irrigation-reaming was continued by Stürmer40 and was based on Pascal’s Law: “Pressure 
applied to a confined fluid at any point is transmitted undiminished throughout the fluid in 
all directions and acts upon every part of the confining vessel at right angles to its inferior 
surfaces and equally upon equal areas”. To put it simple; in order to keep positive pressure 
from being generated, a volume equal to or greater than the volume introduced must flow 
out of the chamber. Viscosity, lumen dimensions for in- and out-flow for irrigation and 
suction, reaming speed, diameter and design of the bore and the design and the flutes of the 
cutter head are important aspects involved in IMP increase. The RIA is a double lumen 
system allowing simultaneous flushing and suction. Fat has a higher viscosity than water and 
to reduce the intramedullary content viscosity, water is applied in the suction-irrigation 
reaming systems. To improve the out- flow, the reamer-shaft diameter was increased and a 
one-step reaming system was created in the RIA system.   
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From the time Küntscher introduced the IMN until today, the reamer head design of the 
reamers without suction and irrigation has changed significantly, from a piston-like reamer 
head design to reamer heads with increasing flutes of the cutter, allowing the cutter to 
better work itself through the intramedullary content and to a lesser degree push the 
reaming debris forward41. This development has also reduced the IMP during reaming 
significantly from levels exceeding 1000 mmHg40,42  to levels below 350 mmHg as 
demonstrated in laboratory studies in Plexiglas tubes filled with a mixture of Vaseline and 
Paraffin oil in 199743. In the same experimental setting a reamer with irrigation and vacuum 
demonstrated a pressure increase of 64 mmHg. In the experimental studies by Goplen et 
al.44, Stürmer et al.40 and Smith et al.45 reaming systems that included irrigation and suction 
demonstrated lesser IMP increase during reaming than a TR system. However, no clinical 
studies, comparing IMP by suction-irrigation reaming with TR have been carried out. A 
recent study from Volgas et al.46 compared the intravasation of bone marrow content, 
evaluated by transesophageal echocardiography, related to reaming with the RIA device 
with a standard reaming device. They found significantly increased amount of fat passing 
through the right heart during reaming with the standard reamer versus the RIA reamer.   
   
HEMOSTASIS 
Blood flow is indispensable in the normal physiologic function of the major organ systems. In 
order to serve its function in organ oxygenation effectively, blood must be in a fluid and non-
coagulated state. The process by which the blood is maintained fluent within the vessels and 
at the same time prevention of excessive injury-related blood loss is called hemostasis. The 
balance between the forces that cause blood to coagulate and those who allow it to remain 
fluid is very delicate and involves several interacting systems. The hemostatic process is 
composed of four major events: 
1. The initial phase is accompanied by vascular constriction due to contraction of the smooth 
muscle in the blood vessels. 
2. The adhesion phase. When the endothelium is disrupted, subendothelial structures are 
denuded, mainly collagen, which binds circulating von Willebrand factor (vWF) and changes 
the conformation to allow binding of glycoprotein-1b (Gp-1b) on the surface of platelets. The 
Gp-Ib functions as a receptor for vWF. During this initial adhesion phase binding of platelets 
to denuded collagen occurs and through this binding and at the presence of additional 
proteins the platelets get activated. Upon activation the platelets release several proteins 
important for the coagulation cascade, as well as small molecular substances like adenosine 
diphosphate (ADP) and 5-hydroxytryptamine (5-HT), which in turn activate additional 
platelets. The activated platelets change their shape to accommodate the formation of a 
platelet plug. 
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3. Thrombus formation. For stabilization of the initially loose platelet plug, a fibrin mesh 
(called clot) forms and merges with the plug. When the plug consists of platelets it is termed 
white thrombus, and when red blood cells are included in the plug it is termed red 
thrombus. 
4. Dissolution of the thrombus. For normalization of blood flow and to resume tissue repair 
the thrombus has to be dissolved. The dissolution of the thrombus occurs through the action 
of plasmin, the major fibrinolytic enzyme. 
There are four major plasma enzyme systems which have an important role in hemostasis 
and control of inflammation. These are the clotting system (coagulation), the fibrinolytic 
system, the complement system and the kallikrein kinin system.  
The accumulation of fibrin must be tightly regulated to prevent unnecessary blocking of 
blood vessels, resulting in tissues with reduced- or absent blood supply. If blood clots too 
easily, thrombosis may occur. When clot formation is impeded, hemorrhage may occur. Due 
to the need of rapid response as well as a tight regulation, the coagulation system involves a 
multistep cascade of enzymes with the major purpose to catalyze the next step in the 
cascade, ultimately resulting in cross-linked fibrin. In this way, the effect of the initial blood 
vessel damage can be quickly magnified, as a single enzyme at the first stage activates many 
copies of the enzyme at the next stage. At the same time, the many levels of interactions 
provide many levels of possible control processes.  
For the evaluation of coagulation activation we have chosen to analyze the plasma levels of 
soluble tissue factor (sTF) and the thrombin-antithrombin complex (TAT).  The most 
important coagulation activation pathway in trauma is the tissue factor pathway, which is 
initiated by the expression of TF. Intramedullary fat that are intravasated by bone fracturing 
and intramedullary procedures is a major source of TF. TAT represent a relatively stable 
complex consisting of thrombin and its inhibitor; antithrombin, and represents the end 
product of the final common coagulation pathway. Once thrombin is formed, the fibrinolytic 
system is triggered. We have chosen tissue plasminogen activator (t-PA) and plasminogen 
activator inhibitor 1 (PAI-1) as indicators for fibrinolysis and fibrinolysis inhibition, 
respectively.  The reason why there is free t-PA in the circulation (up to 5%) is that the 
inhibition of t-PA by PAI-1 takes a few minutes and a small amount of t-PA is left and not yet 
inactivated. The coagulation- and fibrinolysis activation are further described below. 
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THE PLASMATIC CASCADE SYSTEMS 
THE COAGULATION SYSTEM  
The coagulation cascade is activated already at thirty seconds to some minutes post injury47. 
Activation of the coagulation system can follow two pathways; the TF pathway (formerly 
known as the extrinsic pathway) and the contact activation pathway (formerly known as the 
intrinsic pathway). These ultimately converge with the final common pathway that leads to 
clot formation. The pathways of coagulation are inhibited and activated by different 
enzymes.  
The inhibitors of the coagulation system can be divided into three groups; the serine 
protease inhibitors (e.g. anti-thrombin), the vitamin K-dependent glycoproteins (protein C/S 
system and alpha2-macroglobulin (A2M)
48), and the Kunitz type inhibitor group. 
 
THE TISSUE FACTOR PATHWAY (EXTRINSIC) 
The primary pathway for the initiation of blood coagulation is the TF pathway49. TF (also 
called thromboplastin, tissue thromboplastin and FIII) is not normally present in the 
circulation at any more than trace levels. The TF pathway of coagulation is triggered when 
blood gets in contact with TF that is exposed by damaged blood vessels and surrounding 
tissues50,51. TF can also be expressed intravasculary by appropriate stimulation of monocytes 
and endothelial cells50,52-54. In the presence of other plasma proteins (clotting factors); 
mainly Factor VII (FVII) and calcium ions, this leads to the activation of FX, which then 
activates the common pathway of coagulation.  
Activated FVII (aFVII) circulates in a higher amount than any other activated coagulation 
factor, and following damage of the blood vessels, aFVII is exposed to TF, and form together 
the activated complex: TF-FVIIa. TF-FVIIa activates FIX and FX. The prothrombin time (PT) 
test and also PT ratio (= INR) are measurements of the TF pathway activation.  
 
THE CONTACT ACTIVATION PATHWAY (INTRINSIC) 
The intrinsic pathway of coagulation begins with activation of FXII (also named Hageman 
factor), which is released by blood platelets. FXI, prekallikrein, and high molecular weight 
kininogen (HMWK) are also involved in this activation pathway.  The sequential activation of 
FXII, FXI, FIX, and FVIII in the presence of calcium ions results in the activation of FX. FVIII is 
essential for activation of the intrinsic pathway.  The aFX then initiates the common pathway 
of coagulation. The contact activation pathway has a minor role in initiating clot formation, 
but seems, instead to be more involved in inflammation. Activated partial thromboplastin 
time (aPTT) is a measurement of the contact activation pathway. 
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THE FINAL COMMON PATHWAY  
The common pathway begins with the activation of FX. The aFX, together with platelet 
phospholipids, aFV, Ca2+ and prothrombin form the prothrombinase complex, which 
activates prothrombin (FII) to thrombin (aFII) and prothrombin fragments 1 and 2. The 
primary role of thrombin is the conversion of fibrinogen into fibrin, the building block of the 
hemostatic plug. Additionally, thrombin activates FVIII and FV and their inhibitor protein C 
(in the presence of thrombomodulin) and also FXII, FXI and FIX. Thrombin also activates FXIII, 
which in turn participate in forming the cross-linked fibrin clot. Fibrin, as a fibrous protein 
with no enzyme effects, ends this cascade. The primary inhibitor of thrombin in plasma is 
antithrombin. Thrombin and antitrombin form the TAT complex, which is relatively 
stable55,56. 
Fibrin, being insoluble, sticks to platelets and endothelial cells at the site of tissue damage 
and forms a network that, in turn, traps other cells47. In addition, thrombin stimulates 
various cellular functions such as platelet activation, release and aggregation, smooth 
muscle cell mitogenesis, angiogenesis, neutrophil chemotaxis and changes in the endothelial 
cell shape which leads to increased outflow of albumin across the endothelial cell barrier.  
Following the continuing activation of the TF pathway, the coagulation cascade is maintained 
in a prothrombotic state by the continued activation of FVIII and FIX, until down-regulated 
by the anticoagulant pathway. 
 
Figure 1. The figure demonstrates a schematic overview of the coagulation pathway. 
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THE FIBRINOLYTIC SYSTEM 
Once hemostasis is established and the tissue repaired, the clot or thrombus must be 
removed from the injured tissue to restore normal vascular blood flow. This is achieved by 
activation of the fibrinolytic pathway. The process of reorganizing and decomposition of 
fibrin clots, the product of coagulation, is called fibrinolysis. It is stimulated by anoxia, 
inflammatory reactions, and other kinds of stress.  
The end product of this pathway is the enzyme plasmin. Plasmin attacks fibrin at several 
different sites, reducing its size such that it no longer has hemostatic activity. Many 
fragments are formed during this process, and some retain the capacity to polymerize, thus 
some of the early degradation products can compete with fibrinogen for thrombin and act as 
inhibitors of clot formation.  
Plasmin is the main enzyme responsible for the fibrinolytic process. The conversion of 
plasminogen into the active fibrinolytic enzyme, plasmin, occurs at the fibrin surface of the 
blood clot. The initiation of fibrinolysis is regulated by the concentration of active t-PA in the 
region of the thrombus. Plasminogen and its activator t-PA have a high affinity for fibrin and 
form a complex at the fibrin surface.  t-PA is found in most tissues and is synthesized by 
endothelial cells57,58.  The binding of the t-PA results in activation of plasmin on the cell 
surface to prevent, remove or split the clot formations. The concentration of active t-PA is 
controlled by the rate of endothelial secretion of t-PA, the rate of hepatic clearance of t-
PA59, and the inhibition of t-PA by active PAI-I60, which is the principle inhibitor of the 
fibrinolysis61. t-PA and PAI-1 react to form an inactive t-PA/PAI-I complex.  In normal 
individuals the half-time of t-PA is about three to four minutes and for PAI-1 it is less than 
ten minutes62. Free t-PA and also the PAI-1-complexed t-PA are rapidly removed from the 
circulation. The level of t-PA in the plasma is normally low, but can be increased by exercise 
and stress. Activated t-PA and PAI-1 can be measured in plasma. 
Before effective fibrinolysis can occur, the plasmin that is initially formed must saturate the 
plasmin inhibitor that is bound to the fibrin. By extensive activation of fibrinolysis, plasmin 
may exceed the binding capacity of the main plasmin inhibitor, i.e. α2-antiplasmin. When this 
happen A2M, another inhibitor of the fibrinolysis system, may act as a second-line inhibitor.   
 
THE COMPLEMENT SYSTEM 
We analyzed the terminal complement complex (TCC) for the evaluation of the complement 
activation. C5a is probably the most important activation product after trauma, but is 
difficult to detect due to its rapid binding to leukocytes. TCC is found to be a reliable 
indicator of C5a 63 and has a half life of approximately 50 minutes64. The complement 
cascade consists of three pathways, and a common terminal pathway65: 
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1. The classical pathway is initiated by antigen-antibody complexes. 
2. The alternative pathway is initiated by cell and tissue damage, e.g. trauma. 
3. The lectin pathway is similar to the classical pathway, but is not antibody-dependent. 
The pathway is initiated by the binding of lectin to pathogen surfaces. 
The ultimate result of either pathway is the formation of TCC. A controlled activation will 
destroy foreign material like microorganisms and preserve host tissues, whereas an 
uncontrolled systemic activation of the complement cascade may result in tissue destruction 
and organ failure. The alternative pathway is the most important in the trauma patients, and 
also for the activation seen in severe sepsis66-68.   
 
CELLULAR IMMUNITY 
The cell-mediated immunity is an immune response that involves the activation of 
macrophages, natural killer cells (NK), antigen-specific cytotoxic T-lymphocytes, and their 
release of various cytokines in response to an antigen.  
 
CYTOKINES  
Cytokines are small protein molecules that act as signaling molecules used extensively in 
intercellular communication. The widespread distributions of cellular sources for cytokines 
include mainly endo- and epithelial cells and resident macrophages, monocytes, 
granulocytes and lymphocytes. The cytokine binds to a specific receptor and causes a change 
in function or in differentiation of the target cell. Cytokines are regulators of host responses 
to infection, immune responses, inflammation, and trauma. When pro- and anti-
inflammatory systemic reactions are balanced, a state of homeostasis is present. The most 
studied cytokines are the following proinflammatory cytokines: tumor necrosis factor-α 
(TNF-α), Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Interleukin-8 (IL-8) and the anti-
inflammatory cytokine Interleukin-10 (IL-10).   
 
Pro-inflammatory cytokines 
Tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) 
Both TNF-α and IL-1β are pro-inflammatory cytokines that stimulates the secretion of other 
pro-inflammatory cytokines, and IL-1β is probably the initiator of the inflammatory 
response69. IL-1β is produced by macrophages, monocytes, fibroblasts and dendritic cells. 
The main source of TNF-α is the activated macrophages. TNF-α activates lymphocytes 
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(natural killer cells) that result in increased cytotoxicity. A local increase in concentration of 
TNF-α will cause the cardinal signs of inflammation to occur; heat, swelling, redness, and 
pain. TNF-α also acts on vascular endothelium and causes arterial vasodilatation in 
experimental animals, and it promote inflammation and thrombosis70. IL-1β participates in 
the transmigration of leukocytes to sites of infection (and the pathogens) and re-set the 
hypothalamus thermoregulatory center, leading to an increased body temperature. IL-1β is 
therefore called an endogenous pyrogen. IL-1β production in peripheral tissue has also been 
associated with increased sensitivity to pain associated with fever71. Because of the short 
half-life of TNF-α and IL-1β in the circulation (less than 20 minutes and 6 - 8 minutes, 
respectively)72, the maximum serum concentrations  decrease rapidly to not-detectable 
levels and could escape the fixed points of blood sampling72. The normal range of TNF-α is 
0.3 – 5.1 pg/mL73. The expected level of IL-1β in human plasma is less than 1 pg/mL. 
 
Interleukin-6 (IL-6) 
IL-6 is mainly produced by T-lymphocytes and monocytes and holds both pro- and anti-
inflammatory qualities72,74,75. The anti-inflammatory effects of IL-6 are caused by the 
weakening of TNF-α and IL-1β activity by increased release of IL-1 receptor antagonist and 
soluble TNF-receptors75,76. However, the main role of IL-6 is the pro-inflammatory response 
by inducing neutrophil activation and delaying the phagocytic disposal of aging or 
dysfunctional polymorphonuclear leukocytes (PMNs)72.  IL-6 has been considered the main 
mediator of fever and acute inflammatory reaction after surgery77 and also participate in 
inducing the hepatic synthesis of C-reactive protein (CRP)78. 
 
Interleukin-8 (IL-8)                            
IL-8, mainly produced by macrophages, is a pro-inflammatory cytokine and a potent signal 
molecule for activation of PMNs72,79.  
 
Anti-inflammatory cytokines 
Interleukin-10 (IL-10) 
IL-10 is an anti-inflammatory cytokine. The main source of IL-10 is probably T-lymphocytes 
and monocytes72. IL-10 is a potent inhibitor of cytokines such as TNF-α, IL-1β, IL-6, IL-8 and 
IL-12 and has the potential to transfer the host into an immunosuppressive state80. IL-10 
accelerate monocyte apoptosis72. IL-10 inhibit the generation of free oxygen radicals and 
nitric oxide, which are responsible for microbacterial activity against intracellular 
pathogens80,81.  
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INTERACTIONS BETWEEN COAGULATION, FIBRINOLYSIS, COMPLEMENT 
AND CYTOKINES ACTIVATION 
A significant cross-talk between coagulation, fibrinolysis, complement and cytokines exists82. 
All the systems can be looked upon as partners in an inflammation response whose ultimate 
aim is to stabilize disturbances to homeostasis. The inflammation, when extensive, shifts the 
hemostatic mechanisms in favor of thrombosis. The inflammatory mediators IL-1β and TNF-
α, as well as endotoxin, can stimulate the presence of accessible TF and thereby activate the 
TF pathway of coagulation82,83. Inflammatory mediators like IL-6 can increase the 
responsiveness of platelets to thrombin and thereby increase the thrombogenic potential84. 
TF is the most potent trigger of the coagulation system known85. 
It is well established that complement activation, directly or indirectly, promotes blood 
coagulation and thrombosis by increasing TF expression in various cells86,87. For the 
coagulation cascade to work effectively, phosphatidylserine is needed on the cell surface, 
which can be achieved by very potent platelet agonists like C5b9 (complement cascade) or 
the combination of thrombin and collagen88.  Complement split products, like C3b, may 
stimulate the TF synthesis in monocytes which in turn induces activation of the coagulation 
system89. The complement cascade is further activated by thrombin. Thrombin is thought to 
primarily be involved in coagulation activation, but it seems additionally to be involved in the 
inflammatory response through the activation of platelets, which again release substances 
with pro-inflammatory qualities90,91.  Additionally, it is well established that complement 
activation inhibit fibrinolysis by up-regulation of PAI-186,87. Protein S may also represent a 
link between the coagulation and the complement systems and cytokines, and the protein C 
anticoagulant pathway is also participating in the modulation of inflammatory mediator 
responses in the endothelium92. 
 
THE COAGULATION-, FIBRINOLYTIC-, COMPLEMENT- AND CYTOKINE 
RESPONSES IN THE TRAUMA PATIENTS  
Hemorrhage is the most frequent cause of preventable injury-related deaths and is 
commonly associated with coagulopathy93,94. The traditional description of trauma- 
associated coagulopathy views it as directly blood loss, dilution ( due to fluid administration 
or transfusions) or dysfunction of the coagulation proteases (due to hypothermia and/or the 
effect of acidemia on enzyme function). The acute traumatic coagulopathy appears, 
however, to have an endogenous component as a result of combined hemorrhagic shock 
and tissue damage95, and may develop without the exogenous factors such as hemodilution, 
acidemia or hypothermia93,96-99.  In recent literature, the acute coagulopathy in trauma is 
described as initiated by tissue trauma and hypoperfusion and characterized by systemic 
anticoagulation and hyperfibrinolysis, not as a dysfunction of the coagulation proteases100. 
The term “personalized medicine” has recently been used in an editorial by Holcomb 
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describing the future approach to coagulopathy in trauma patients, combining  the 
utilization of the valgus nerve, transfusion of biologically active fluids containing proteins, 
stem cells and reconstituted lymphilized blood products101. This biologically active fluid 
should not only increase  blood pressure and reverse the coagulopathy, but also participate 
in tissue healing and restore vascular stability. This vision of the future is, however, based on 
hypothesis generating, but highly interesting, possibilities  focused on interplay with 
endothelial barrier function (Syndecan-1), catecholamines, inflammation and 
coagulation102,103. The clinically relevant definition and the etiology of the acute traumatic 
coagulopathy are still not clear. 
By normal hemostasis, tissue injury results in endothelial disruption with production of aFV, 
aFX, thrombin and aVIII. In the absence of hypoperfusion, tissue trauma activates the TF 
pathway, generating thrombin, which cleaves fibrinogen to form fibrin104. In the presence of 
shock and tissue damage, however, the clearance of thrombin is delayed which increases its 
binding to thrombomodulin (expressed by the endothelium) and the forming of complexes 
containing anticoagulant properties. Less thrombin is available to split fibrinogen, and 
thrombin-thrombomodulin complexes activate protein C, which again inhibit the TF pathway 
(through cofactors V and VIII) and PAI-1 (by cleaving thrombin-activated fibrinolysis inhibitor 
into its active form). Activation or dysfunction of platelets and endothelium and fibrinogen 
generation participate, together with a relative inhibition of stable clot formation by 
anticoagulant and fibrinolytic pathways to the coagulopathy100.  
Orthopedic surgery has in general a greater influence on coagulation activation than general 
surgery, due to bone traumatization which includes both local hypercoagulation in veins 
draining the operation fields and systemic activation of coagulation105. The local activation is 
initiated by vascular endothelial damage, exposure of subendothelial procoagulants, e.g. TF, 
and results in thrombin and fibrin formation and an immediate TAT response49,95,106,107. The 
systemic effects may be associated with intravasation of bone marrow and intramedullary 
fat, which has experimentally been demonstrated to cause systemic intravascular 
coagulation with aggregation of platelets and formation of fibrin clots108. Femoral shaft 
fractures and the stabilization of these have been associated with coagulopathy, but this 
association has been questioned.  
The lungs appear to have a prominent position in the activation of coagulation in bone 
preparation procedures due to lodging of procoagulant material in the pulmonary capillaries. 
This process in turn contributes to local deposition of fibrin and formation of pulmonary 
microthrombi109. Additionally, increased TF activity of circulating monocytes, as 
demonstrated after elective orthopedic surgery110, allows pericellular fibrin formation to 
occur, which again contributes further to a hypercoagulable state. The lodging of bone 
marrow-derived conglomerates in the pulmonary circulation represents the mechanical 
obstruction of the lung capillaries. This step is followed by a toxic and biologic effect that is 
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associated with vasculitis, pneumonitis, and a local inflammatory reaction111. Procoagulant 
bone marrow material occluding the pulmonary capillaries is broken down by tissue lipase to 
glycerol and pulmonary tissue toxic concentrations of free fatty acids112,113.  This, in 
combination with other factors, results in damage of the capillary endothelium and 
subsequently provokes low pressure pulmonary edema and a disruption of the capillary 
network with confluent hemorrhage112,113.  The polymorphonuclear leukocytes are activated 
by damaged endothelium. The free fatty acids increase the endothelium damage and 
thereby lead to a further activation of the polymorphonuclear leukocytes. ARDS is an 
inflammatory disease of the pulmonary parenchyma, where to bone marrow constituents 
may be a trigger for the develpoment112,114,115.  
Inflammation can potentiate coagulation with increased risk of thrombosis through the 
down-regulation of the vascular anticoagulants. Activated leukocytes and monocytes results 
in sequestration of platelets on which coagulation complexes can assemble, and to the 
triggering of coagulation and also finally to the decrease of the effectiveness of the protein C 
pathway as an anticoagulant104.  
In trauma patients the adversed outcome of bleeding disorders is not limited to the deaths 
related to acute blood loss, but include also the consequences of a prolonged shock state 
with coagulation activation integrated in the inflammatory response with a increased 
susceptibility of development of SIRS, MOF, ARDS, pneumonia and sepsis. There are, post 
injury, mainly two systemic mediator systems with potential to jeopardize organ function116-
118. The first is the hyperinflammatory stage (SIRS) characterized by elevated inflammatory 
mediators74,117,119,120 that, when exaggerated, results in tissue damage121,122. The other is the 
compensatory anti-inflammatory response (CARS)117,120,123 that can transfer the injured 
patient into an immunosuppressive stage, with increased endotoxin tolerance and increased 
risk of infections124-127. When pro- and anti-inflammatory systemic reactions are balanced, a 
system of homeostasis is present. When unbalanced, the patient may be threatened by the 
mechanisms that should actually protect them128. SIRS is presumably beneficial in most 
patients117, and resolves usually during the recovery.  
Several events are assumed to influence the activity of the different cytokines, such as body 
temperature129, soft tissue trauma130, major fractures 31,121,  severity of tissue injury33,81,131-
136, infections137, hypovolemic shock138, numbers of transfusions139 and the extent of surgical 
procedures131,140. The magnitude of the inflammatory response seems to correlate with the 
extent of injury (operation or trauma)33,131,132,134,136.  Secondary operations, if performed in 
polytraumatized patients while they still have increased level of posttraumatic inflammation, 
may act as second insults and precipitate late multi organ dysfunction syndrome 
(MODS)34,136,141. Cytokines are presumed to be important mediators in the development of 
MOF/MODS, ARDS, post injury infections and sepsis, as well as efficient predictors of 
outcome in severely injured patients3,69,124,126,142-150.  
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Evaluating the inflammatory response to trauma and surgery still involves major challenges. 
The inflammatory response is thought to be a result of the summary of the local tissue injury 
and the immunologic reaction that is caused by local necrosis, bacteria and hypoxia. By 
reviewing the literature, it is still difficult to sort out the pro-inflammatory and anti-
inflammatory response that is related to the initial trauma and that which is related to a 
surgical intervention.  The effects151-154, the origin72,151, the mechanisms of secretion and the 
interactions of the various participants of the inflammatory response are partly unclear and 
inconsistent73,75,80,142,155-157.  To what extent the systemic levels of cytokines represent a spill-
over from a local environment is still unclear158-160.  Several authors have demonstrated 
increased levels of cytokines at the site of injury or infections158-161. IL-6, IL-8, and IL-10 have 
been demonstrated to be increased in fracture/soft-tissue hematoma159,160. Krohn et al.158 
demonstrated increased IL-6 and stable TNF-α concentration in blood drained from the 
operation area when compared with the concentrations in circulating blood after major 
orthopedic surgery. 
The time-related response of cytokines to the surgical procedure with intramedullary 
reaming has been studied31-33,162, but whether the response is related to surgery or the 
trauma per se could be difficult to ascertain and most studies only measure one or a few 
components of a single cascade system. IL-6 is the most studied cytokine in trauma patients. 
A post injury association between early increased IL-6 levels, high ISS, late adversed 
outcome, and extent of tissue degree is well established120,133,136,163.  IL-6 peaks 4 - 24 hours 
post injury and persists for 3 - 10 days72,133. After a surgical procedure a peak level is 
demonstrated 6 - 12 hours after the procedure77. Nast-Kolb et al.126 presented a study on 
severely injured patients (mean ISS 40) with significantly more pathologic values of IL-6 and 
IL-8 in non-survivors post injury compared to survivors, and with a peak much broader and 
culminating somewhat later (18 - 32 hours) than in the patients that survived (6 - 18 hours).  
Giannoudis et al.163 demonstrated increasing IL-6 levels that peaked on the first 
postoperative day in polytraumatized patients (NISS 31.5) in which femoral shaft fractures 
were initially stabilized. A strong correlation between IL-6 levels >200 pg/mL and a SIRS state 
and IL-6 levels >300 pg/mL and risk of complications like pneumonia, MOF and death was 
found. IL-6 was measured on the first, third, fifth and seventh day, no secondary IL-6 peak 
level was described. The study from Morley et al.164 from 2008 provided evidence that 
intramedullary reaming of femoral shaft fractures can cause significantly increased local 
levels of IL-6. They found, however, no second-hit phenomenon with a procedure-related 
further elevation of peripheral IL-6 levels when measured at 24 and 72 hours post 
procedure. In that study all patients with femoral shaft fractures without focus on ISS level, 
were included. Pape et al.141 examined blunt polytraumatized patients (ISS 34) and found 
high IL-6 levels on admission. Major surgery was performed on day two to four post injury, 
and a secondary IL-6 peak was observed at the fourth  day post injury. Another study by 
Pape et al.31, however, demonstrated significantly increasing IL-6 levels after operative 
procedures, but it is difficult to determine whether these increased levels represented an 
28 
 
increase related to the initial trauma or to the operative trauma.  Giannoudis et al.165 
demonstrated peak IL-6 levels on the first day after admission in patients with femoral shaft 
fractures, but a  timely relation between IL-6 levels and the operative procedure of the 
femoral shaft fractures was not defined, and no additional IL-6 activation related to the 
procedure of femoral stabilization could bee seen.  
The role of TNF-α in the trauma patients has still not been definitely settled. This might be a 
result of the short half-life and thereby the increased possibility of missing a possible peak 
level related to injury or surgical procedures. Increased levels of TNF-α has been reported to 
be associated with morbidity and unfavorable prognosis in septic patients161, and has been 
reported elevated in bronchoalveloar fluids of ARDS patients and elevated in plasma after 
trauma73. In the study by Spielmann et al.73, no correlations were, however, found between 
TNF-α levels and SIRS or MODS the first six days post trauma, and further there was no 
correlation between systemic TNF-α levels and the total severity of the injury73. Serum TNF-
α was unchanged in the fracture group throughout the investigation.  
The demonstration of peak IL-1β levels has the same limitations as that for TNF-α; a short 
half-life makes it difficult to demonstrate. A brief IL-1β peak was observed at three hours 
after fracture in a study of Kobbe et al.166. 
Levels of IL-8 are reported elevated in bronchoalveolar lavage in patients with nosocomial 
pneumonia, ARDS and lung injury143. A large increase in circulating IL-8 is associated with the 
development of ARDS133,144. 
IL-10 is a potent inhibitor of production of cytokines such as IL-1β, TNF-α, IL-6, IL-8 and IL-12 
and has simultaneously the potential to transfer the host into an immunosuppressed 
state80,167. Both biphasic and single peak IL-10 levels were measured 1 - 24 hours post injury 
and postoperatively81,162,166, with a decrease towards baseline levels 24 - 72 hours 
postoperatively80. IL-10 response correlate with the severity of injury and posttraumatic 
complications80,81,149, and is also increased in drainage fluid and serum after major 
orthopedic surgery168,169. Smith et al.162 demonstrated that reamed femoral nailing was 
associated with higher IL-10 levels and with greater immunosuppression than the unreamed 
intramedullary nail. Despite that IL-10 is thought to have a protective effect by inhibiting the 
pro-inflammatory response129, several authors have demonstrated increased mortality and 
morbidity related to elevated circulating levels of this cytokine124,125,147.  
Blocking or interfering with the effects of cytokines with an anti-cytokine therapy has been 
tried in various studies. Blocking IL-1 or TNF has been highly successful in patients with 
rheumatoid arthritis, inflammatory bowel disease, or graft-vs.-host disease. Such strategies 
have, however, been without success in humans with sepsis or trauma119. Blocking of the 
complement cascade in animal models of ischemia-reperfusion injuries have shown 
promising results170,171, but human studies are lacking. Recent studies has described the 
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mechanisms were valgus nerve stimulators inhibit cytokines172, but the application of this 
knowledge is not investigated related to trauma. 
The complement activation occur very early after trauma (within 30 minutes post injury)173, 
mainly via the alternative pathway174 , and has been implicated in the pathogenesis of 
several inflammatory and immunological diseases, including SIRS, ARDS, sepsis and MOF175. 
In a study on polytraumatized patients TCC correlated with ISS, and C3a were significantly 
increased in non-survivors when compared to survivors176. No studies have demonstrated a 
relation between IMN and complement activation, but in relation to elective orthopedic 
surgery increased TCC levels are found systemically and in drained blood at the location of 
the operative procedure158. 
 
ORTHOPEDIC SURGERY AND CARDIOPULMONARY COMPLICATIONS 
Severe injuries including long bone fractures result in extensive tissue injury, intravasation of 
bone marrow content and coagulation and inflammation activation. A cardiopulmonary 
response is also present177,178. The exact nature, as well as the sequelae of this response 
might be unclear, but they are likely to participate in the later development of life-
threatening complications.  
Pulmonary fat embolization was found in 62 - 96% of the cases in autopsy reports from 
trauma patients with fractures179-181.  In an experimental model a biphasic embolic load has 
been demonstrated after fracturing of the bone and the subsequent reaming and nailing of 
the fractures.  The first and the highest embolic shower was related to fracturing, and the 
secondary peak embolic load was observed related to the reaming procedure182. In the 
studies of Wenda et al.183,184 an IMP greater than 50 mm Hg correlated with embolic 
showers. In experimental models, an IMP higher than 1000 mm Hg in the femoral cavity has 
been demonstrated40,42. Intramedullary femoral reaming and nailing may induce 
intravasation of bone marrow contents as a result of increased IMP183-186. These embolic 
elements may lodge in the pulmonary circulation and result in cardiopulmonary 
complications114,186-189.  
Intravasation of bone marrow content is experimentally proven by histological investigations 
and sonographic visualization of embolic echoes after manipulation of bone marrow and 
increased IMP183,184. The magnitude of hemodynamic and pulmonary changes after PE has 
been demonstrated to be a function of both size and numbers of the emboli in addition to 
the underlying pre-existing state of cardiopulmonary function187,190. The amount of emboli 
needed to cause a detectable cardiopulmonary dysfunction has still not been established. 
The vessels in a normal pulmonary circulation are easily dilated when the pressure increases, 
therefore both mean pulmonary artery pressure (MPAP) and pulmonary vascular resistance 
(PVR) may remain almost unchanged despite widespread vascular occlusion. In older 
30 
 
literature it has been estimated that as much as 30 - 50% of a previous normal pulmonary 
circulation in humans has to be occluded before hemodynamic alterations can be detected 
191. The hemodynamic consequences of microscopic pulmonary embolism and 
microthrombosis associated with conditions like ALI and ARDS could be circulatory failure 
due to the effect of increased MPAP on the right ventricle186. The right ventricle can be 
expected to fail when 75% of the pulmonary vasculature becomes obstructed192. Such failure 
leads to end-diastolic dilatation and displacement of the septum wall, which results in 
reduced end-diastolic filling of the left ventricle and further aggravation of circulatory 
failure190,193. Pulmonary dysfunction following intravasation of bone marrow contents is also 
reported to be aggravated by secondary problems such as hypoxia, hypovolemia, pulmonary 
vasoconstriction, pre-existing pulmonary disease and massive blood transfusions. Bone 
marrow fat is primarily filtered by the lungs, which are the first organ affected when no 
intracardial shunt is present. If PE causes massive occlusion of the lung vessels 
intraoperatively, it can result in immediate heart failure. Both the mechanical and the 
biochemical pulmonary effects of PE result in an immediate and serious impairment of 
oxygen transfer from the airways to the hemoglobin. The hypoxemia results from an 
increased pulmonary venoarterial admixture (pulmonary shunt). Perfusion disturbances 
through arteriolar and alveolar capillary occlusion by emboli can account for the increased 
alveolar dead space (ventilated and nonperfused alveoli), but not for hypoxemia. The mixing 
of arterial and venous blood in the lung may have other causes like extensive alveolar 
consolidation by hemorrhage or edema producing non-ventilated but perfused alveoli. 
In a recently published review of 20 experimental studies on IMN as a second hit 
phenomenon, the authors concluded that i) a second hit consisting of reamed IMN resulted 
in a consumption of coagulation factors, ii) hemodynamic function parameters were 
transiently affected, and iii) pulmonary function parameters were only affected when the 
initial injury included a pulmonary injury194. 
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AIMS OF THE STUDIES 
 
The aims of the present studies were: 
1. to compare the procedure-related effects of intramedullary reaming with the RIA 
system with a TR system in an experimental model and  
2. to explore the additional procedure-related effect of reamed IMN in severely 
traumatized patients 
 
In Paper I we evaluated the IMP increase during reaming with the RIA and the TR technique.  
In Paper II we evaluated the effect of reaming with the RIA and TR technique on 
cardiopulmonary function parameters and numbers of embolisms. 
In Paper III we evaluated the effect of reaming with the RIA and TR technique on the 
coagulation-, fibrinolytic- and cytokine responses. 
In paper IV we investigated the associations between low-pressure intramedullary reaming, 
pulmonary embolism, cardiopulmonary alterations and inflammatory response. 
In paper V we evaluated the procedure-related effects of reamed IMN in severely injured 
patients. 
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METHODOLOGICAL STRATEGIES 
MATERIALS 
EXPERIMENTAL STUDIES (PAPER I-IV) 
We used Norwegian landrace pigs, age 3-4 months, weight 30-40 kilogram (15 female, 13 
male animals). The animals were from the same farm. The genetic aspect was not 
investigated.  
Twenty-eight animals were used in the experimental studies. The same study animals were 
used in Paper I-IV. In ten animals we used the RIA system, in another ten the TR system was 
used, and eight animals constituted the control group. Two of the animals in the RIA group 
were used in a pilot study, and had a shorter stabilizing period after soft tissue preparation 
before intramedullary surgery was performed. One animal in the TR and one in the control 
group were not included in the analyzes due to anesthesia-related events. One animal in the 
RIA and one in the TR group died of massive bleeding, due to dislocation of catheters after 
the intramedullary surgery was performed. The group distribution of the animals is not a 
true randomized inclusion, even though a randomly allocation to the groups was described 
in Paper I, Paper II and Paper III. The first two animals were used as pilots for testing the RIA 
system in our model. Thereafter, the procedure changed for every third animal (TR or RIA) 
and the last 8 animals were the controls. The animals were, however, picked randomly at 
the farm and delivered at Institute for Experimental Medical Research (IEMR). A flow-chart 
of included and excluded animals are given in Figure 2. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Flow-chart of included and excluded animals in paper I-IV.  
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Paper I: The two pilot animals were included in this paper. One animal in the TR group was 
excluded due to anesthesia-related events prior to intramedullary surgery. The two animals 
with larger bleeding were included (one in the TR and one in the RIA group). One animal in 
the RIA group was excluded due to a perioperatively inflicted femoral fracture, as were three 
animals in the TR group due to perioperative perforation of the distal medial femoral cortex. 
After the exclusion of these animals the RIA group consisted of nine animals and the TR 
group of six animals. No control animals were included. 
Paper II and Paper III: Six of the 28 animals were excluded due to anesthesia-related events 
prior to operation, exsanguinations or a shorter than protocol stabilization time, leaving 22 
animals for final analyzes; 8 in the TR, 7 in the RIA and 7 in the control group. 
Paper IV: Six of the 28 animals were excluded due to anesthesia-related events prior to 
operation, exsanguinations or because they were used in the pilot study, leaving 22 animals 
(8 in the TR, 7 in the RIA and 7 in the control group) for final analyzes of correlations. When 
analyzing correlations related to IMP measurements the control group was not included. 
The physiology of the digestive system in pigs is rather similar to that of humans. The adult 
porcine heart is approximately the size of the human heart and is also anatomically and 
physiologically similar to the heart of the humans195. 
The porcine hemodynamics is similar to that of human beings. The lung tissue volume of 
small and large animals makes up nearly the same fraction of body volume of 6% 196,197. 
Mammals in general, have a tidal volume of one-tenth of their maximal inspiration lung 
volume, irrespective of their body size196. Human tidal volume is approximately 500 ml198 
and at maximal inspiration the gas volume is approximately 5000 ml.   
The porcine model, with 75 ml blood per kilo body weight, offers sufficient quantity of blood 
for sampling. Knowledge of the species-specific normal blood parameters is essential when 
selecting the appropriate model for studies. Porcine models have been widely used in 
research on coagulation and fibrinolysis since the components of the porcine and the human 
coagulation- and fibrinolytic systems are assumed to be similar195, but porcine plasma is 
hypercoagulable compared with human plasma199-201. The hypercoagulability is probably not 
solely caused by increased coagulation activity, but also by a relatively modest fibrinolytic 
activity or even absent increase in fibrinolysis. TAT level reflects the formation of thrombin 
(prethrombotic state) and is an indicator of the inhibition of thrombin by its natural inhibitor 
antithrombin III, and can be detected in several species (e.g. mice, dogs, sheep, pigs2) with 
the analyzing kit based on polyclonal antibodies against human antithrombin III and 
prothrombin used in the present studies. Roussi et al.199 concluded that TAT could be used 
to follow the modifications of blood coagulation activation during experimental procedures 
in pigs. The porcine levels of TAT and fibrinogen, are elevated compared to human levels201, 
but have a wider range of variation199,200. At sampling, care should be taken not to 
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manipulate catheters and samples and thereby cause elevated levels. And related to 
interventions, it is of importance to carefully follow the time schedule.  In the study of Velik-
Salchner et al.201 from 2006, normal mean TAT levels in porcine blood was 20.2 μg/L while 
the mean TAT level in human blood was 2.6 μg/L. Roussi et al., on the other hand, found  
normal porcine plasma to have TAT levels of 9.3 μg/L199. Measurements of PAI-1 plasma 
concentration in pigs has demonstrated a wide range of levels199. t-PA plasma concentration 
in pigs is similar to the human concentration of t-PA199.  The application of immunoreagents, 
developed for applications in humans, can therefore be used for detection of both of t-PA 
and PAI-1 activity199. Commercial kits for the TF (thromboplastin) levels in pigs are not 
available, and lack of cross-reactivity between pigs and humans makes it not possible to use 
human assays202. 
CLINICAL STUDY (PAPER V) 
During the inclusion period from May 2003 to December 2004, 43 patients between 18 and 
65 years of age, with femoral shaft fracture, were admitted to Oslo University Hospital, 
Ullevaal. By selecting patients that were severely injured and suitable for early IMN, 15 
patients were eligible for inclusion, 12 patients were included. A detailed description of the 
patient material is given in Figure 3. 
Oslo University Hospital, Ullevaal, was in 2003/2004 the local trauma hospital for 250 000, 
the major trauma hospital for 550 000, and the trauma referral hospital for 2.5 million 
people. Annually, approximately 1100 patients were enrolled in the hospital-based trauma 
registry (numbers from 2008). Approximately 40% of these patients were severely injured. 
Empirically, 80% of the patients with femoral shaft fractures admitted to Oslo University 
Hospital, Ullevaal, were severely injured patients. 
A recently published study from Sweden203, describing as many as 6409 patients with 
femoral shaft fractures, demonstrated an incidence of all femoral shaft fractures in all age 
groups to be 10 fractures in 100 000 persons per year. The two major mechanisms of injury 
were falls on the same level (50%) and transport accidents (17%). A significant number of 
fractures occurred among elderly patients after low-energy trauma. The material on femoral 
shaft fractures in the present study differed significantly from that study. 
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Figure 3.  The flow chart describes which of the patients with femoral shaft fractures 
admitted to the hospital in the given period of time were included in the study. 
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STUDY DESIGN 
INTERVENTION 
EXPERIMENTAL STUDIES (PAPER I-IV) 
Before starting of the study we evaluated the technical applicability of the available RIA 
equipment in the chosen research animal. RIA reamers were available with the smallest 
diameter of 12 mm, which reduced the choice of experimental models to large animals. We 
used young pigs with a body weight of 30 to 40 kilograms. These animals, however, had an 
open distal femoral epiphysis. To determine the localization of the epiphysis and the shape 
and dimensions of the femur, radiographs of the femur of one pig used for other research 
purposes were taken (Fig. 4a and 4b). Furthermore, the femora of two other pigs were 
excised and divided longitudinally for easier identification of the epiphysis that was located 
at the level of the proximal lateral edge of the patellofemoral cartilage (Fig. 4c) at a distance 
of 11 - 12 centimeters from the top of the trochanter. This was important to ensure the 
placement of the intramedullary pressure catheter above the epiphysis in order to secure 
correct IMP measurements and to ensure no risk of damaging the catheter during reaming. 
As no x-rays or fluoroscopy were used during surgery, the placement of the catheter above 
the epiphysis had to be correlated to anatomical landmarks. The lateral edge of the patella 
was palpated and a longitudinal incision made. In the mid-line of the distal femur at the level 
of the most prominent part of the proximal, lateral edge of the patellofemoral cartilage a 
hole was drilled at the desired location. 
   
Figure 4. Radiographs (4a and 4b) of a pig femur and a longitudinally divided pig femur (4c) 
with distal femoral epiphysis (black arrow). 
 
4a 4b 4c
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Prior to the present studies, we devided the femur longitudinally after reaming with the RIA 
device to evaluate the size of the reamer related to the size of the femur (Fig. 5). The 
planning of the study included also a surgical approach. 
 
Figure 5. Longitudinally divided pig femur post RIA reaming. 
 
Anesthesia 
We chose a model in which the animals were extubated and kept alive for three days after 
surgery. In acute experiments on large animals, an open tracheotomy is normally performed. 
As the animals were to be extubated oral intubation was chosen. During the two hours post 
procedure period, the surgical anesthesia was maintained by infusions of propofol 
(Diprivan®, 20 mg/ml, AstraZeneca, Caponago, Italy) and fentanyl (Fentanyl®, 50 μg/ml, 
Alpharma, Linz, Austria). This method, which is similar to that utilized in many trauma 
patients, gives the opportunity to regulate the level of analgesia and consciousness within 
short time. The pigs need, however, larger doses of drugs than humans to achieve adequate 
effect. The possible effect of propofol or fentanyl on blood coagulation, fibrinolysis or 
cytokines is not known. In the current study all animals received the same anesthesia. As 
propofol is suspended in 10% soy bean oil, the most concentrated solution was used to 
avoid interference of exogenous fat with the parameters to be measured. 
 
Insertion of a femoral vein catheter 
An 18-gauge catheter was inserted through a cut-down in the left femoral vein.  This 
catheter was used for perioperative venous blood sampling. 
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Vascular Access Port, VAP 
Two hours after the insertion of the nail, an artery catheter that was inserted in the carotid 
artery was cannulated under the skin and connected to a VAP that was placed in a 
subcutaneous pocket in the posterior area of the neck. This procedure made it possible to 
sample blood from awake animals without sedation. The catheter was installed arterially to 
minimize the risk of blood clotting and occlusion of the catheter. The VAP was flushed with 5 
ml of a solution consisting of 500 ml sodium chloride (0.9%), 500 ml Macrodex® (60 mg/ml 
with sodium chloride) (Pharmalink AB, Upplands Väsby, Sweden) and 15 ml heparin (Heparin 
Leo®, 5000 U/ml, LEO Pharma A/S, Ballerup, Denmark). 
 
Pulmonary artery (PA) catheter 
Installing a catheter in the pulmonary artery is the only possible method of continuous and 
direct monitoring of the parameters needed for the calculation of pulmonary vascular 
resistance (PVR). In the first two animals, the pilot, we introduced the flow-directed PA 
catheter (744HF75, Swan-Ganz CCOmbo CCO/SvO2 catheter 7.5F, Edwards Critical-Care 
Division, Irvine, CA, USA), by using a percutaneous technique via the right femoral vein (the 
left femur was operated on). This procedure proved cumbersome; we therefore changed the 
site of introduction to the left internal jugular vein using an open technique with a midline 
incision at the anterior aspect of the neck.  
 
Intramedullary pressure monitoring 
The insertion of the pressure monitoring catheter was performed following the information 
obtained during the pilot phase.  A transducer tipped pressure monitoring catheter, zero 
adjusted, was inserted and fixed with a compression cap.  The tip of the catheter was placed 
about 2 mm beyond the end of the bolt. The catheter was connected to both a display unit 
for continuous graphic observation of the IMP and to a monitor (Camino1MPM1, San Diego, 
USA) for recording of pressure levels at fixed time points. The measurement range of the 
monitor was -10 to +250 mm Hg; the average pressure of the last 0.5 seconds is given 
instead of the continuous pressure. We recorded the IMP as described in Table 1. The 
graphic pressure observations were used to evaluate the recorded reaming time with a 
pressure greater than 50 mm Hg. The time between the reaming steps was not included in 
the reaming time in the TR group. In particular during the first reaming steps in the TR group 
very high peak IMP levels for very short time periods (not measurable) were observed. 
Whether these represent artifacts or are caused by embolic masses, is unclear.  
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Reaming and nailing of the femur 
We used no radiography during the reaming and nailing procedure. The location of the 
femur and the anatomical characteristics of the pig were studied prior to the start of the 
study. Reaming and nailing of left femur was performed with the pig in the right lateral 
position. The trochanteric fossa was prepared through a longitudinal incision; the medial 
cranial part of the femoral biceps muscle was partly divided, carefully avoiding the sciatic 
nerve. The marrow canal was then opened with an awl, a guide wire introduced 
intramedullary and antegrade reaming was performed. The femoral neck is very short in the 
pig, and the opening of the femoral canal has to be located as close to the cartilage of the 
femoral head as possible. In the RIA group, a 12 mm reamer head (Fig. 6a and 6b), which is 
the smallest available, was used. The application of smaller animals or thinner femora 
appears as a difficult if not impossible exercise if the intension is to keep the outer cortex 
intact. The reamer was connected to a suction tube (Fig. 6c) with an internal lumen of 5.5 
mm and a suction force of 30 mm Hg. In the TR group, the nailing was performed after 
sequential reaming with increasing steps of 0.5 mm in reamer diameter (9.5 - 12 mm). A 
standard Groβe-Kempf nail, cut at a length of 10 cm, with a diameter of 10 mm was 
introduced. 
 
 
Figure 6. The figure shows the RIA reamer head (Fig. 6a and 6b, below and left) and the 
traditional reamer head (Fig. 6a and 6b, above and right). The RIA is demonstrated on Fig. 6c 
with a connection to a flushing tube (white, thick arrow) and a suction tube (white, thin 
arrow). 
 
6a 6b 
6c 
41 
 
Lung specimens  
The animals were sacrificed and autopsied on the third postoperative day. The lungs were 
excised immediately after the death.  Two tissue samples were harvested from the periphery 
of each lung lobe; one anteriorly and one posteriorly located, and two histological sections 
made from each sample which resulted in twenty sections per animal. The hearts were 
examined to exclude the presence of a patent foramen ovale or any right-to-left intracardiac 
shunt. The lung specimens were fixed in 4% paraformaldehyde. For light microscopy the 
specimens were washed and processed using a tissue processor, starting with 50% ethanol 
and finally being embedded in paraffin wax. Histological sections were cut at a thickness of 4 
m and were conventionally stained with hematoxylin and eosin and covered with mounting 
medium (Permount, Fischer Scientific Ltd., Ottawa, Canada). The size of the emboli (in large, 
medium or small pulmonary arteries, arterioles, venules or veins) and emboli content (fat, 
fibrin, bone marrow, bone fragments and combinations of these) were noted. The total area 
of the lung histology preparations was calculated using Auto Sketch 6.0 (1998) planimetry 
program. The incidence of embolisms was expressed as numbers of emboli per square 
centimeter lung area. 
 
CLINICAL STUDY (PAPER V) 
In the clinical study the inclusion criteria were severely injured patients (ISS ≥ 16), aged 18 - 
65, with a femoral shaft fracture suitable for early IMN and no previous femoral shaft 
fractures or operative interventions in the femur. The inclusion in the study did not influence 
the choice of treatment method or the time to perform the operative procedure. 
 
Pulmonary artery catheter 
In 8/12 patients the PA catheter was introduced via the subclavian or jugular veins. In one 
patient an attempt of catheter insertion was unsuccessful. In three patients time constraints 
precluded catheter insertion previous to the surgical procedures. 
 
BLOOD SAMPLING AND HANDLING 
In order to discriminate between a local activation at the location of intramedullary 
intervention and the additional pulmonary activation, we sampled arterial-, mixed venous- 
and femoral vein blood simultaneously. Mixed venous blood from the pulmonary artery 
contains venous blood from both the upper and lower body, in contrast to samples 
withdrawn from a central venous line, where the samples reflects the venous drainage from 
the upper body.  
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EXPERIMENTAL STUDIES (PAPER I-IV) 
For the evaluation of coagulation TAT was studied. Fibrinopeptide A and Prothrombin 
fragments 1 and 2 are not available as commercial porcine kits, neither is sTF. 
For the evaluation of fibrinolysis and inhibition of fibrinolysis t-PA activity and PAI-1 activity 
were studied. The soft tissue damage during surgery is minor, but an effect on at least the 
coagulation and fibrinolytic system is to be expected. In the pilot study we used a stabilizing 
period of only 45 minutes and received elevated baseline TAT levels. We decided therefore a 
stabilizing period of 75 minutes after the soft tissue preparation. 
We analyzed the terminal complement complex (TCC) for the evaluation of the complement 
activation. 
For the evaluation of pro- and anti-inflammatory cytokines, we chose to analyze and 
evaluate changes in circulating IL-1β, TNF-α, IL-6, IL-8 and IL-10. The sandwich ELISA 
technique can specifically detect and quantitate the levels of soluble cytokines.  
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Table 1. The table shows time points for blood sampling and the different sampling 
locations, cardiopulmonary recordings and intramedullary pressure registration in the 
porcine model; 75 minutes after completion of soft tissue preparation (baseline) (A), after 
reaming (B), immediately after insertion of the nail (C), and at 30 minutes (D), two (E), six (F), 
24 (G), 48 (H) and 72 (I) hours after insertion of the nail. 
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CLINICAL STUDY (PAPER V) 
The first arterial blood samples were withdrawn in the emergency room at hospital 
admittance.  
For the evaluation of coagulation pathway, sTF and TAT were studied. For the evaluation of 
fibrinolysis and inhibition of fibrinolysis t-PA and PAI-1 were studied. We used specific assays 
for the evaluation of human t-PA activity and antigen and PAI-1 activity, which were all 
cross-reactive with porcine components.  
The terminal complement complex (TCC) was analyzed for the evaluation of the complement 
activation. 
Pro- (IL-1β, TNF-α, IL-6, IL-8) and anti-inflammatory (IL-10) cytokines were analyzed with 
colometric sandwich ELISA (IL-8) or chemiluminescent ELISAs that can specifically detect and 
quantitate concentrations of soluble cytokines. The samples were first analyzed using the 
normal colorimetric sandwich ELISA, but since several samples had to be diluted because 
they were out of the range of the assay, we choose to switch to the chemiluminescent 
ELISAs with increased sensibility and a wider dynamic range to eliminate the need for extra 
dilutions. We reanalyzed the already analyzed samples. The results used in the study, 
however, were the results from samples analyzed with the same kit.   
 
CARDIOPULMONARY FUNCTION RECORDINGS AND CALCULATIONS 
As pulmonary embolism was a central issue in these studies, the alterations in the 
pulmonary circulation were important. To obtain the parameters needed for the calculation 
of PVR (according to the formula: [MPAP – pulmonary capillary wedge pressure (PCWP)] / 
cardiac output (CO) x 80), we inserted a flow-directed PA catheter in the pulmonary artery. 
Accurate measurement of CO is important for the PVR calculations, thermodilution by a PA 
catheter is still considered the gold standard for clinical CO measurements. Figure 7 
demonstrates the association of the different parameters that can be monitored and used 
for evaluation of cardiopulmonary function. The PA catheter was installed through the right 
ventricle and into the pulmonary artery where the MPAP was measured. When the balloon 
at the end of the catheter is inflated, the pressure sensor at the end of the catheter will 
measure the pressure in the pulmonary vein which corresponds to PCWP. 
The PA catheter was connected to a Vigilance monitor for continuous peroperative 
monitoring of CO, mixed venous oxygen saturation (SvO2) and body core temperature. Mean 
artery pressure (MAP), MPAP, central vein pressure (CVP) and heart rate were monitored 
continuously, PCWP was measured intermittently, and SVR and PVR were calculated from 
the measured parameters. Alveolar PaO2 was calculated by the equation PAO2 = ((PB-PH2O) x 
FiO2 – PaCO2/0.8) (PB = barometric pressure, PH2O = Water vapor pressure, 47 mmHg, 0.8 is 
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the normal gas exchange ratio or respiratory quotient), and the PAO2 – PaO2 differences were 
calculated. 
 
Figure 7. The figure demonstrates the location and associations of pressures and gas 
saturations in the circulation. 
 
STATISTICAL METHODS 
All statistical analyzes in this thesis were performed with the Statistical Package for Social 
Science (SPSS Inc, Chicago, IL, USA) version 12.0 (Paper I), version 15.0 (Paper II) and version 
16.0 (Paper III, Paper IV and Paper V). 
 
EXPERIMENTAL STUDIES (PAPER I-IV) 
All animal studies should be designed to include a minimal numbers of animals considering 
both the ethical and the economical aspects. Reliable sample size calculations are often 
difficult to achieve because neither the magnitude of the effect size nor variability of the 
data is known when planning the study. The sample size calculations depend on the effect 
size, the variability, significance level and desired power. When not using large animals, this 
can be estimated using a pilot study. A statistical sample size calculation, using sample size 
formulas, was not performed. We used the advice from the University Hospital Senior 
Medical Statistician who recommended at least 6 - 8 “successful“ study animals in each 
study group. To allow for a 20% drop-out rate, 10 animals were initially included in each 
reaming group. In most animal studies, as in the present studies, the information on 
numbers needed is lacking. Only in one experimental study204 referred to in Paper I-V 
statistical power was described. The authors set the statistical power of 50%, given the small 
size of samples. When making calculations posterity e.g. for the presence of PE (Paper II), 
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previous research could give us an indication of the amount of pulmonary emboli, the way of 
describing the amount, however, was not equivalent. But, if we in Paper II chose a clinically 
relevant difference of 0.100 (which we in fact do not know), included eight animals, used p ≤ 
0.05, the power (when using “nomogram for calculating sample size or power” by Altman205) 
was 80 - 85%. Most of the previously conducted experimental studies42,45,183,184,204,206-212 
have relatively few individuals in each study group (≤ 6 individuals), several studies have a 
poorly or missing description of statistics183,184,207,209-211,213  and several studies had a short 
observation period (< 60 minutes)45,211,214.  We used the hypothesis that any major 
differences could be demonstrated when including a minimum of 6 – 8 animals in each study 
group. The numbers of animals needed should be kept low, but sufficient. In this study we 
might have a type 2 error, and thereby possible false nonsignificant results, or results that 
were not clear. 
Paper I 
In this study we compared the IMP increase between the two reaming groups. We had no 
control group. Kolmogorov-Smirnov test of normality demonstrated normally distributed 
values. The results were presented as means and standard error of the mean (S.E.M.). The 
differences between the groups were demonstrated by using independent samples t-test. 
Differences were considered significant at P values ≤ 0.05. 
Paper II 
In this study we investigated the numbers of PE and hemodynamic and pulmonary 
alterations in two different reaming groups and a control group. The data were presented as 
group means and S.E.M. Independent samples t-test was used when comparing numbers of 
emboli, body weights, carcass weights and lung weights between the groups. Repeated 
measurement (mixed-between-within) analysis of variance (ANOVA) was used as a 
multivariate test when comparing the groups simultaneously at several time points. The 
values used for this test were the differences from baseline level. Differences were 
considered significant at P-levels ≤ 0.05. Statistical analysis of differences between the 
animals that died of PE and the rest of the TR group were not performed due to small 
number of animals. 
Paper III 
In Paper III the coagulation-, fibrinolysis- and cytokine activation after reaming with two 
reaming methods and a control group were studied. Independent samples t-test were used 
when comparing groups at various time points. Repeated measurement (mixed-between-
within) ANOVA was used as a multivariate test when comparing the groups simultaneously 
at several time points. Differences were considered significant at P-levels ≤ 0.05. When 
values were below detectable levels, the lower detectable levels were chosen for the 
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statistical analysis. Statistical analysis of differences between the animals that died of PE and 
the rest of the TR group were not performed due to small number of animals. 
Paper IV 
In this paper we investigated the relationship and the strength of relationship between the 
results collected in Paper I, Paper II and Paper III. The correlations were obtained by the use 
of Pearson product-moment correlation coefficient (r). The statistical significance of r was 
provided. For IMP and number of PE absolute values were used, and for cardiopulmonary 
alterations and inflammatory-, fibrinolytic- and coagulation responses the difference (Δ 
values) from baseline levels (A) were used. Correlations were considered significant at P-
levels ≤ 0.05 and considered strong when r = < -0.500 or > 0.500. 
Paper V 
In this study we further explored the effect of IMN on different parameters measured over 
time. Normally distributed data were presented as group means and S.E.M. Paired-samples 
t-test was used for evaluation of increasing or decreasing levels between two measuring 
points. Non-parametric statistics were used when the scores, evaluated by Kolmogorov-
Smirnov test and histogram, were not normally distributed, as given for red blood cell 
transfusions (RBCT), coagulation-, fibrinolysis- and cytokine activation. We used median 
levels for presentation. Wilcoxon Signed Rank Test was used as the non-parametric test 
describing increasing and decreasing levels between two measuring points. Differences were 
considered significant at P-levels ≤ 0.05. 
 
ETHICAL CONSIDERATIONS 
Animal models allow investigations that would otherwise be impossible in humans. The use 
of animals in research must be conducted according to the recommendations in order to 
avoid pain, suffering, distress, discomfort and harm to the animals. When performing an 
animal study both ethical and economical aspects have to be considered carefully. The 
numbers of animals needed should be kept low, but sufficient. In paper I-IV we have used an 
experimental model and these studies were conducted in accordance with “Regulations on 
Animal Experimentation”215 under The Norwegian Animal Welfare Act and approved by the 
Norwegian Animal Research Authority. 
The clinical study was approved by the Regional Ethics Committee and the Norwegian Data 
Inspectorate. Informed written consent was obtained from all subjects included in Paper V. 
In this study we did discuss the need for the insertion of a PA catheter. The seriousness of 
the injuries made some kind of hemodynamic monitoring necessary anyhow, and as the 
effect of PE was an essential issue, we decided to insert the PA catheter. The direct 
complication rate related to PA catheters is low, estimated to 0.1 – 0.5%216. The most 
common serious complications related to PA catheter include arrhythmias, injury to the 
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lung, thromboembolism, and sepsis. PA catheterization performed by experienced team is in 
multicentre studies demonstrated to be a safe procedure216,217. When this study was 
planned, the use of PA catheters was more widespread than it is today. Today, methods 
analyzing the pulse-contour are frequently used for the estimation of CO. As this method 
alone does not measure the lung venous pressure, it does not give us the information 
necessary to calculate the pulmonary vascular resistance.   
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SUMMARY OF THE PAPERS  
 
PAPER I 
The influence of a one-step reamer-irrigator-aspirator technique on the 
intramedullary pressure in the pig femur 
A one-step RIA was developed to reduce the IMP during the reaming procedure of long 
bones. This study compared the IMP during reaming with the RIA system with the IMP 
during reaming with a TR system in pig femora.  Fifteen Norwegian landrace pigs were 
included in the final analysis. With a transducer-tipped pressure monitoring catheter the IMP 
in intact pig femora, reamed with either the one-step RIA device (n =9) or a TR system (n = 
6), was monitored before the start of the reaming procedure, during the reaming and nailing 
procedure and 10 minutes after the nail was inserted. The highest IMP during reaming was 
33 ± 8 mm Hg (mean ± S.E.M.) in the RIA group and 188 ± 38 mm Hg (mean ± S.E.M.) in the 
TR group.  In conclusion the use of a one-step RIA technique in the pig femur induced 
significantly lower IMP increase than the use of a TR system. 
 
PAPER II 
Cardiopulmonary response to reamed intramedullary nailing of the femur 
comparing traditional reaming with a one-step reamer-irrigator-aspirator reaming 
system; an experimental study in pigs 
Intramedullary reaming and nailing increase IMP and cause intravasation of bone marrow 
content. Intravasated bone marrow content may result in pulmonary microembolism and 
cardiopulmonary alterations. The clinical manifestations of intravasated bone marrow 
content depend on the emboli size and amount. In this study we evaluated the 
cardiopulmonary alterations related to the two different reaming devices; the RIA system 
and the TR system. Hemodynamic and pulmonary effects were investigated during the 
reaming and nailing procedure and for two hours postoperatively. The animals were 
sacrificed after 72 hours and lung tissue collected for evaluations of amount of pulmonary 
emboli (PE). For the final analyzes seven animals were included in the RIA group, eight in the 
TR group and seven in the control group. We found no significant differences in 
hemodynamic or pulmonary function parameters between the reaming groups. The number 
of emboli per cm2 lung tissue was approximately 50% higher in the TR group than in the RIA 
group. This difference, however, was not sufficient to cause statistically significant group 
differences for cardiopulmonary function parameters.  We concluded that intramedullary 
reaming and nailing induced a hemodynamic procedure-related effect, but with no 
significant difference between reaming with the RIA system and reaming with a TR system. 
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The numbers of PE were higher (ns) in the TR group, and in the TR group two animals died of 
PE. No animals died of PE after reaming with the RIA system. 
 
PAPER III 
Coagulation-, fibrinolysis-, and cytokine responses to intramedullary nailing of the 
femur. An experimental study in pigs comparing traditional reaming and reaming 
with a one-step reamer-irrigator-aspirator system 
Operative procedures on trauma patients represent a second insult and the extent of the 
surgical procedures influences the magnitude of the inflammatory response. We 
investigated whether the RIA system would cause a lesser inflammatory response than the 
TR system. Coagulation-, fibrinolysis- and cytokine responses were studied in arterial-, mixed 
venous- and femoral vein blood peroperatively and until two hours after the nail was 
inserted for demonstration of local, pulmonary and systemic activation of the cascade 
systems. At 6, 24, 48 and 72 hours after the nail was inserted arterial blood samples were 
withdrawn. In both reaming groups significantly procedure-related activation of coagulation 
and fibrinolysis were demonstrated. The local and pulmonary activation of coagulation and 
fibrinolysis were more pronounced related to TR than related to reaming with the RIA 
system. The cytokine response, mainly represented by increased levels of IL-6, showed 
significantly higher peak levels in femoral vein blood in the TR group. The arterial IL-6 levels 
were higher (ns) than the mixed venous levels indicating an additional pulmonary activation 
of IL-6. We concluded that a procedure-related inflammatory response was demonstrated in 
both reaming groups and that this inflammatory response was more pronounced in the TR 
group than in the RIA group. 
 
PAPER IV 
Intramedullary fat embolization. Can its magnitude and effects be modulated by 
low pressure reaming in a porcine model? 
Increased IMP may result in intravasation of bone marrow content and the extent of clinical 
manifestations related to the intravasation probably depends on the quantity of bone 
marrow content entering the blood system. In Paper I-III we demonstrated increased IMP, 
increased inflammatory response and increased numbers of emboli (ns) related to TR 
compared to reaming with the RIA system.  In this study, however, we investigated the 
correlation between IMP increase, regardless of type of reamer, and inflammatory response, 
pulmonary embolization and cardiopulmonary alterations. A strong correlation was found 
between increased IMP and increased coagulation- and cytokine responses. Increased IMP 
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did not correlate to numbers of emboli. Number of emboli correlated strongly with 
increased coagulation- and cytokine responses. A correlation between coagulation and 
cytokine activation was also demonstrated. No clinical relevant correlations were observed 
between increased IMP or numbers of emboli and changes in cardiopulmonary function 
parameters. In this study we confirmed the connection between increased IMP, increased 
coagulation activation and cytokine activation and the magnitude of PE. We concluded that 
by lowering the IMP (as obtained with the RIA system) the magnitude and the effects of the 
bone marrow intravasation were reduced.  
 
PAPER V 
Intramedullary nailing of femoral shaft fractures. Does the procedure have an 
impact on the cardiopulmonary- and inflammatory responses in severely injured 
patients? 
Early IMN of femoral shaft fractures in severely injured patients is an important procedure in 
early trauma management, but has also been associated with increased inflammation, MOF 
and morbidity. In this study we evaluated to what extent the cardiopulmonary function 
parameters and inflammation becomes further affected by primary femoral IMN in severely 
injured patients. Twelve severely injured patients with femoral shaft fractures that were 
primarily stabilized with a reamed intramedullary nail were included in this study. The 
patients were mean 27.6 years old. ISS was 31. Chest abbreviated injury scale (AIS) was 3.7. 
All the patients had additional extremity- and chest injuries. In 8/12 patients a PA catheter 
was inserted. Cardiopulmonary function parameters were recorded or calculated, and serial 
blood samples were collected for evaluation of coagulation-, fibrinolysis- and cytokine 
activation peroperatively and the first three postoperative days. The clinical course and 
complications were recorded. No increased coagulation- or fibrinolysis activation related to 
the intramedullary procedure could be demonstrated. Peak levels of TNF-α, IL-6 and IL-10 
were delayed compared to other studies. We did not find evidence for an additional 
pulmonary component in the increased cytokine levels as we suggested in the experimental 
study in Paper III. A transient procedure-related effect on PVRI was present. The additional 
IMN-induced traumatic changes in severely injured patients seemed to be modest compared 
to the total extent of injury. The transient procedure-related hemodynamic response was 
probably a result of the procedure-related bone marrow content intravasation. The 
coagulation- and fibrinolysis response to the IMN seemed to drown in the extensive general 
trauma response. The late cytokine peak levels might be related to the IMN procedure and 
the postoperative course was prolonged by pneumonia (7/12), ALI (3/12), ARDS (3/12) and 
sepsis (3/12). All patients except one fulfilled the SIRS criteria. These severely injured 
patients had a high incidence of inflammatory related complications.  
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GENERAL DISCUSSION 
METHODOLOGICAL CONSIDERATIONS 
Blood sampling and analyzing assays (Paper III, Paper IV and Paper V) 
One problem concerning several previous studies from other research groups is the missing 
information of detectable levels of the cytokines. In the recent years several improvements 
of the commercial assay kits, such as high-sensitivity kits, have become available. Studying 
the literature on this issue, one of the challenges is to know what we are comparing. Former 
studies that showed no differences from normal values should be interpreted with care.  
Most authors mention the sensitivity of the assay kits; fewer authors mention the range or 
the lower detectable level of the assay kits. Available porcine assay kits are not as sensitive 
as modern, high sensitivity human kits, and therefore some of the changes that could have 
been detectable in human, are below the detectable concentration in the porcine kits. 
For analyzes we primarily chose the assays that our laboratory normally uses, but as several 
levels were above/below the range of these assays, we reanalyzed the plasma samples with 
more sensitive assays with a wider range. Surprisingly, when correlating the first values with 
the reanalyzed values, greater discrepancies than expected were found also when the values 
were within the range of both assays. This information was communicated to the producing 
company. We used the same assays for all animals, and we used the same assays for all 
included patients. 
Another unclarified aspect is the possible effects of freezing and thawing on the stability of 
plasma cytokines.  In the present studies errors caused by repeated thawing cycles seem 
unlikely because the samples were thawed and frozen again only once. Another aspect that 
might have influenced the cytokine levels in the clinical study is that the samples were 
frozen for a long time before they were analyzed. This could have reduced the levels218.  
In the porcine study the animals were conscious when samples were obtained the first, 
second, and third day. They received no tranquillizing drugs prior to the blood sampling. The 
effect of stress on the cytokine levels is unknown. 
The possible circadian variation in cytokine levels is insignificant in the porcine model (Paper 
III)219 as the animals were operated at the same time of the day. In the clinical study (Paper 
V), this, however, could have an influence. 
Krohn et al. reported no effect on the systemic concentration of cytokines after autologous 
transfusion of shed washed erythrocytes during an operation158. In the clinical study (Paper 
V) the amount of blood products are listed, but the material is not adjusted for the different 
blood products administration. 
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The pig femur (Paper I-IV) 
Since the length of the pig femur relative to body size is about 50% shorter than in humans 
(approximately 12-13% of the body length versus 25% in humans) the potential volume of 
bone marrow content that can be extruded into the vascular system of pigs is significantly 
smaller in the pigs than in humans. Additionally, the trabecular bone is denser, the cortical 
bone less dense, and the venous circulation probably better in the porcine femur when 
compared to human adult bone220. Both a wider and shorter bone and denser trabecular 
bone are conditions that probably lower the IMP increase during intramedullary reaming 
and thereby also the intravasation of bone marrow content. These reflections make the 
possibility to observe an embolic load comparable to reaming procedures in humans 
unlikely. However, no other animal model, with the exception of maybe a monkey model 
(which today is seldom used in experimental models), could better reflect the human 
conditions. 
Another topic of discussion is whether to use a fracture- or osteotomy model or a model 
with an intact femur. The length of the pig femora in the young animals used for the present 
studies was approximately 15 cm, and the distance from fossa piriformis to the distal 
femoral epiphysis was 11-12 cm41. An osteotomy or a shaft fracture may act as a vent and 
allow bone marrow contents to leak into surrounding tissues. The maximal pressure effects 
occur as the reamer or nail (by unreamed nailing) enters the distal main fragment40. The 
short femur and additionally the location of the femur in the pig make a fracture model 
complicated and unreliable. On the other hand, a fracture may represent a “first-hit” in the 
pulmonary circulation, which might have made a procedure-related increase in PVR easier to 
detect. An osteotomy of the femur as a fracture substitute, however, is possible, but with 
the length of the porcine femur, the created IMP would probably be too low to test the 
study hypothesis. As the effect of bone marrow embolization during reaming and nailing was 
one goal of our study, we do not think that inducing a femoral fracture prior to surgery 
would have increased the pathophysiological changes as it would probably lower the 
amount of bone marrow content extruded into the vascular system. In an experimental 
study of femoral IMN on intact and fractured canine femora the release of triglycerides was 
greater in a non-fracture model221, suggesting more bone marrow content intravasation in 
intact femora. To achieve a maximal bone marrow content intravasation the bone in the 
large animal model must be kept intact and the reaming and nailing of the femur must 
include the distal part of the femur222.  These considerations made us decide to use a non-
fracture model. 
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Pulmonary injury (Paper II) 
In a recently published review of 20 studies on intramedullary nailing as a second hit 
phenomenon in experimental studies, the authors summarized the results that second hit 
represented by reamed IMN resulted in a consumption of coagulation factors. The 
hemodynamic function parameters were transiently affected, and the pulmonary function 
parameters were only affected when the initial injury included a pulmonary injury194.  In 
several studies a pulmonary contusion was included in the experimental design222-224, but 
with huge variations in time from pulmonary contusion to IMN. A pulmonary contusion 
added in the experimental model could have affected the pulmonary circulation, which 
might have made a procedure-related increase in PVR easier to detect. As we employed a 
chronic model, inducing a chest injury would have made postoperative extubation difficult 
and would probably cause pain and suffering for the animals. The other choice could have 
been to include a pulmonary injury and reduce the study period, but in that case the studies 
of coagulation-, fibrinolytic- and cytokine activation had to be restricted to some hours after 
the surgical procedure. 
 
Age of the animals (Paper I) 
We used young animals with a body weight of 30 to 40 kilograms. These animals, however, 
had open epiphysis. The difference in bone density between cortical and trabecular bone in 
these animals is lesser than in adult human bone. This could contribute to the cases of bone 
perforation during the reaming and nailing procedure. The use of older animals of the same 
race is no alternative, due to the size of the animals. We could have used minipigs, but they 
are significantly more expensive. Another alternative could be the use of sheep, if the sheep 
femur has the dimension to allow intramedullary reaming with a 12 mm reamer head 
without perforating the cortex. 
 
Pulmonary embolism (Paper II) 
One of our goals was to create a model in which the amount of bone marrow content 
intravasation made the pathophysiological consequences of such intravasation possible to 
detect and evaluate. 
This evaluation, however, is complex; both as to the estimation of volume of bone marrow 
material entering the circulation, and the evaluation of the potential harmful effects. The 
actual presence and estimation of the volume of bone marrow content in the blood stream 
could, in a semiquantitative manner, be detected by echocardiographical verification or 
examination of the fat emboli material withdrawn from venous blood during IMN. Due to 
the complexity of this experimental model, such investigations were not included. 
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Retrospectively, obtaining an estimate of the volume of embolic material would have been 
interesting. We tried to evaluate the amount of bone marrow content intravasation by 
examining the numbers of emboli per square centimeter lung tissue. Exactly this method has 
not previously been described. In the literature several methods of analyzing the amount of 
pulmonary emboli have been applied, and the methods are often poorly described. In 
experimental models the highest concentration of emboli was found within the first 
postoperative day, with emboli equally distributed to all lung lobes207,225. With regard to the 
highest concentration of emboli alone, the preferable time for lung tissue collection, would 
be a day after IMN.  By doing that, however, we would probably miss the peak level of e.g. 
IL-6. 
 
Pulmonary artery catheter (Paper V) 
Pulmonary artery catheterization was introduced into clinical practice in 1970226. The use of 
PA catheters to guide clinical strategy has been a matter of discussion. At the PA catheter 
consensus conference in 1997, a recommendation was to use the PA catheters in trauma, 
the use of PA catheters was uncertain when related to SIRS, shock and hemodynamic 
instability227. The PA catheter has the ability to accurately assess CO, MPAP and PCWP, 
which are the needed values for PVR calculation ([MPAP- PCWP]/CO x 80). Even though 
MPAP as well as CO can be estimated by echocardiography, the PA catheter is the only 
method offering exact measurement of all parameters involved in PVR calculation. In cases 
where PVR is no central issue, monitoring or calculation of CO is usually sufficient for the 
evaluation of oxygen supply and systemic vascular resistance (SVR) ([MAP - CVP]/CO x 80). 
Today, frequently applied methods used for the estimation of CO are based on analyzing the 
pulse-contour of the arterial pressure (PICCO, LIDCO, Vigielo FlowTrack), but still, when 
questions related to PE and increased PVR is a vital issue, the gold standard is the monitoring 
and calculations achieved by the PA catheter. The analyzes of the pulsecontour is sufficient 
for CO estimation in most patients, but are not useful in patients with heart rhythm 
disorders, and this method is not useful for the calculation of PVR. As the effect of 
pulmonary embolism was an essential issue, and thereby the PVR, we decided the use of a 
PA catheter. 
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DISCUSSION OF MAIN RESULTS 
 
The main results in this thesis are: 
From the experimental studies: 
 TR resulted in higher IMP than RIA reaming (Paper I) 
 TR resulted in 50% higher numbers of pulmonary emboli than RIA reaming (Paper II) 
 Reaming and nailing with both reaming systems resulted in cardiopulmonary changes 
with no significant differences between the reaming systems (Paper II) 
 Two animals in the TR group died of PE, none in the RIA or the control group (Paper II 
and III) 
 The procedure-related coagulation- and fibrinolysis activation was more pronounced 
in the TR than in the RIA group (Paper III) 
 IL-6 peaked 6 hours post procedure and the local activation of IL-6 was more 
pronounced in the TR group compared to the RIA group (Paper III) 
 Numbers of emboli and IMP correlate with coagulation- and fibrinolysis activation 
(Paper IV) 
 Numbers of emboli, IMP and cardiopulmonal function parameters were not correlated 
(Paper IV) 
 Coagulation- and fibrinolysis activation correlated with cytokine activation (Paper IV) 
 
From the clinical study: 
 The total systemic trauma response was mainly related to the initial trauma (Paper V)  
 No discernible coagulation- and fibrinolysis response was demonstrated related to 
IMN in severely injured patients (Paper V) 
 In the severely injured patients a transient procedure-related hemodynamic response 
was demonstrated (Paper V) 
Increased IMP associated with femoral reaming and nailing has been seen as a cause for the 
systemic complications. Küntscher introduced IMN as early as 193935,36. He was also the first 
to address the systemic problems related to this procedure. Since that time, evolutions 
within several fields related to trauma patients and equipment have taken place. The 
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intramedullary procedure-related complications are probably, due to better reaming 
devices, reduced compared to earlier. Previous studies have described IMP greater than 
1000 mm Hg40,42.  In Paper I the IMP, however, was mean 188 mm Hg. The intensive care 
medicine has achieved enormous improvements228,229. In the 1970s more aggressive attitude 
towards operations on severely injured patients which until then had been treated 
conservatively pending better times17,230, was launched. The reamer head design has 
changed from a piston-like design to reamer-heads with deep grooves and also taper formed 
designs, unreamed nails had been introduced, and during the last year’s different devices 
including suction and irrigation during reaming have also been introduced. All the equipment 
modifications have been made in order to reduce the temperature and IMP increase during 
reaming of long bones. Stürmer was the first to describe the use of suction and irrigation 
already in 198640,231. In 2003 the next papers on suction or suction and irrigation were 
published232,233. A poster presentation of a cadaver study demonstrating low pressure 
reaming by RIA was presented in 2002234. The present paper (Paper I), however, is the first 
study published which has demonstrated lower pressure by reaming with the RIA device 
than with a TR device. Several publications concerning the RIA equipment and the 
application of it has recently been published43,44,46,235-246. The correlation between IMP and 
embolic showers has been proven, and embolic showers have been demonstrated in the 
circulation already at an IMP at 50 mm Hg184,187. 
Increased IMP, which is thought to be responsible for the systemic response related to IMN, 
was studied in Paper I, the results of a reduction of IMP were studied in Paper II and III. 
Intravasation of bone marrow content and the microembolization of bone marrow content 
are observed after fractures 179-184 and intramedullary bone surgery182-184. No other studies 
on the RIA device concerning numbers of PE, coagulation-, fibrinolysis- and cytokine 
activation or cardiopulmonary alterations has been published prior to the start of this study. 
Other reaming systems including suction and irrigation published before Paper I have not 
included these aspects. Pape et al.247 showed in 2005 that the systemic IMN-related effects 
could be minimized by the use of RIA in sheep which were also exposed to unilateral 
pulmonary contusion. In our experimental model, both reaming systems were associated 
with pulmonary emboli, cardiopulmonary alterations, coagulation-, fibrinolysis- and cytokine 
activation, with mainly more pronounced changes in the TR than in the RIA group.  
The extent of danger of performing IMN in severely injured patients has frequently been a 
topic of discussion, both prior to19,28,187,211,214 and following the present studies22,25,30,194,248.  
In Paper V, an IMN-related response mostly seemed to drown in the huge response from the 
initial trauma. The remaining question, however, is, was the IMN procedure responsible for 
the increasing cytokine levels and thereby participating to the very high complication rate? 
The TNF-α, IL-6 and IL-10 responses did not correlate to observed peak levels in other 
publications72,77,133,162,166 and they appear to rise too early to be caused by the coming 
complications.  
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MAIN CONCLUSION  
 
The main conclusions of this thesis are: 
1. Reaming with the TR involved greater systemic response than reaming with the RIA 
reamer. 
2. The additional effects of IMN in severely injured patients are difficult to sort out.  
In Paper I, we found that the IMP increase during reaming with the TR technique was 
significantly higher than during reaming with RIA technique.  
In Paper II we found that both reaming systems induced a hemodynamic procedure-related 
effect with no significant difference between the systems. The numbers of PE were higher 
(ns) in the TR group, and in the TR group two animals died of PE. No animals died of PE in the 
RIA group. 
In Paper III we found a procedure-related inflammatory response in both reaming groups, 
and this response was more pronounced in the TR group.  
In paper IV we found that by lowering IMP, the magnitude and the effects of the bone 
marrow intravasation was reduced. 
In paper V we found a transient procedure-related hemodynamic effect of the IMN in 
severely injured patients and a delayed, when compared to other studies, peak cytokine 
levels. We could not demonstrate a procedure-related response on coagulation- and 
fibrinolytic systems.  
 
 
60 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
FURTHER RESEARCH 
 
Future investigations have to show whether the use of less invasive surgical techniques, such 
as RIA, will decrease the rate of postoperative organ failure, in particular lung complications, 
in the trauma patient. 
Whether a selective manipulation of immunologic systems may reduce the systemic 
inflammatory response and improve the outcome of severely traumatized patients warrants 
further studies  
The most frequently used guides for resuscitation are markers for global circulation like 
blood pressure, urine output, heart rate, base deficit and serum lactate levels22.  These can, 
however, not rule out occult tissue hypoperfusion. In the future better markers of 
coagulation and inflammation141,249 and/or more sensitive measurements of tissue 
oxygenation250 may guide the optimal time for orthopedic procedures more accurately.  
In the human study, Paper V, a notable high frequency of inflammatory-related 
complications, such as pneumonia, SIRS, ARDS, ALI and sepsis, were observed. The early 
postinjury role of bacteria in these patients needs to be studied with more sensitive and 
better analyzing methods. If an association to bacteremia  is found, targeted treatment at an 
early stage could reduce morbidity and severe complications in these patients. 
The role of  endogenous and/or exogenous stem cells in repairing tissue damage is unclair, 
might be of importance and needs to be defined. Beiermeister et al.251 demonstrated the 
mobilization of hematopoietic progenitor cells into peripheral blood and than sequestered in 
damaged tissue post trauma. In our animal model we included blood sampling for the 
evaluation of stem cell related to the reaming methods, as the mobilization of stem cells to 
the circulation possibly may have an impact on bone healing as well. However, the applied 
method evaluating side population cells was not successful.  
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ERRATA 
 
Page 10:  “The acute onset of bilateral infiltrates on antero-posterior chest radiographs” is 
changed to: 
 Acute onset 
 Bilateral infiltrates on antero-posterior chest radiographs 
 
Page 20:  The primary inhibitor of thrombin in plasma is antithrombin. Thrombin and 
antitrombin form the TAT complex, which is relatively stable49,55,56. Ref. 49 is removed. 
 
Page 33 and 34: Figure 2 that was presented to the opponents and the text on page 33 and 
34, described that:”One animal in the RIA and one in the control group were not included in 
the analyzes due to anesthesia-related events. Two animals in the TR group died of massive 
bleeding”. This is not correct. The correct description of the groups is: One animal in the TR 
and one in the control group were not included in the analyzes due to anesthesia-related 
events. One animal in the RIA and one in the TR group died of massive bleeding. 
 
Page 39: The size of the reamers was described as (9 mm - 12 mm) the correct size is (9.5 - 
12 mm).  
 
Page 50: The time points for arterial blood sampling are changed from 24, 48 and 72 hours 
to 6, 24, 48 and 72 hours.  
 
Page 57:  Küntscher introduced IMN in 1939 (not 1950) and the references are from 1948 
and 1950. Ref. 36 is added.  
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Abstract: 
Background: Early intramedullary nailing (IMN) of long bone fractures in severely injured 
patients has been evaluated as beneficial, but has also been associated with increased 
inflammation, multi organ failure (MOF) and morbidity. This study was initiated to evaluate 
the impact of primary femoral IMN on coagulation-, fibrinolysis-, inflammatory- and 
cardiopulmonary responses in polytraumatized patients. 
Methods: Twelve adult polytraumatized patients with femoral shaft fractures were included. 
Serial blood samples were collected to evaluate coagulation-, fibrinolytic-, and cytokine 
activation in arterial blood. A flow-directed pulmonary artery (PA) catheter was inserted prior 
to IMN. Cardiopulmonary function parameters were recorded peri- and postoperatively.  The 
clinical course of the patients and complications were monitored and recorded daily.  
Results:  Mean ISS was 31 ± 2.6. No procedure-related effect of the primary IMN on 
coagulation- and fibrinolysis activation was evident. TNF-α increased significantly from 6 
hours post procedure to peak levels on the third postoperative day. IL-6 increased from the 
first to the third postoperative day. IL-10 peaked on the first postoperative day. A procedure-
related transient hemodynamic response was observed on PVRI two hours post procedure. 
11/12 patients developed SIRS, 7/12 pneumonia, 3/12 ALI, 3/12 ARDS, 3/12 sepsis, 0/12 
wound infection. 
Conclusion: In the polytraumatized patients with femoral shaft fractures operated with 
primary IMN we observed a substantial response related to the initial trauma.  We could not 
demonstrate any major additional IMN-related impact on the inflammatory responses or on 
the cardiopulmonary function parameters. A transient cardiopulmonary response related to 
IMN was demonstrated. Delayed arterial TNF-α, IL-6 and IL10 peak levels were observed, 
and it could be questioned whether these were related to the procedure.  
 
Trial registration: ClinicalTrials.gov Identifier: NCT01042132.  
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Background 
Early intramedullary nailing (IMN) has, in several studies, been associated with reduced 
pulmonary complications and mortality[1-6], whereas in other studies early IMN has been 
associated with increased inflammation, multi organ failure (MOF) and morbidity[7-9]. 
Severe trauma results in a generalized inflammatory response that can pose a threat to the 
organism. In trauma patients, operative procedures, such as IMN, represent a second insult, 
and the ideal time for such treatment, to pose as little harm as possible, has been a topic of 
discussion[1, 10]. The  impact of primary femoral IMN on coagulation-, fibrinolysis-, 
inflammatory- and cardiopulmonary responses in polytraumatized patients was analyzed in 
the present study, with the intention to study the additional procedure-related impact. 
 
Methods 
Material 
This study was approved by the Regional Ethics Committee (ref. 02066). Informed consent or 
assent was obtained from the patients or their representative prior to inclusion in this study. In 
cases when the patients were unable to give personal consent at hospital admission, the 
personal consent was given posterity.  
 
Patients between 18 and 65 years of age, with femoral diaphyseal fracture suitable for initial 
IMN within 24 hours post injury were included.  The exclusion criteria were previous femoral 
shaft fracture, pathological fracture, femoral deformities or pregnancy.  
Between May 17th 2003 and December 6th 2004 43 adult patients between 18 and 65 years of 
age with femoral shaft fractures were admitted to the hospital. An overview of the patients 
and the inclusion process is given in Figure 1. We compared the results from the severely 
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injured patients subjected to primary IMN with three patients that were initially externally 
fixated within 24 hours post injury and had secondary IMN after 6 - 10 days.  
 
Details concerning age, gender, mechanisms of injury and associated injuries were recorded. 
The injury severity was assessed according to the Abbreviated Injury Scale (AIS) and scored 
by a certified AIS-registrar[11, 12]. The overall severity of the injuries was calculated 
according to the Injury Severity Score (ISS) and New Injury Severity Score (NISS)[13, 14]. 
The time from injury to hospital admittance and to IMN, AO classification, Gustilo Anderson 
classification of open fractures, and amount of blood products transfused were recorded. The 
clinical course of the patients and complicationswere monitored and recorded daily. Number 
of days in the intensive care unit (ICU) was also noted. Severely injured patients were defined 
as patients with ISS ≥ 16[15, 16]. The definitions of systemic inflammatory response 
syndrome (SIRS) and sepsis were according to the Consensus Conference of the American 
College of Chest Physicians and the Society of Critical Care Medicine of 1992[17]. The 
definitions of acute lung injury (ALI) and ARDS were according to the American-European 
Consensus Conference on Acute Respiratory Distress Syndrome of 1994[18].  
 
Cardiopulmonary monitoring  
An 18-gauge arterial line was placed in the radial artery in all patients for continuous 
recording of arterial pressures. A flow-directed pulmonary artery (PA) catheter (744HF75, 
Swan-Ganz CCOmbo CCO/SvO2 catheter 7.5F, Edwards Critical-Care Division, Irvine, CA, 
USA) was inserted prior to IMN in 8/12 patients for continuous peri- and postoperative 
monitoring of indexed cardiac output (CI) and mixed venous oxygen saturation (SvO2). Mean 
pulmonary artery pressures (MPAP), central venous pressures (CVP) and pulmonary capillary 
wedge pressures (PCWP) were also monitored. In the remaining four patients a pulmonary 
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catheter was not inserted due to unsuccessful procedure (n = 1) or logistical difficulties (n = 
3). Indexed systemic (SVRI) and pulmonary vascular resistance (PVRI) and alveolo-arterial 
oxygen (PAO2 – PaO2) differences were calculated using kPa as the unit for gas pressure, the 
latter by the equation: [(95 x FiO2) – (PaCO2/ 0.8)] – PaO2. Hemodynamic and lung function 
parameters were recorded at time points as described in Table 1. The arterial and PA catheters 
were removed when the patient left the ICU, or at latest on the third postoperative day. In the 
patients initially treated with external fixation and nailed secondarily, the PA catheter was 
inserted prior to secondary nailing. Registrations and calculations were performed during 
IMN and the three following days or for a shorter time period when the patient left the ICU 
earlier. 
 
Surgical procedure 
All patients had general anesthesia with the exception of one, who received spinal anesthesia. 
A standard antegrade technique was used for reamed IMN (Bicut Intramedullary Reamer 
System, Stryker, Trauma GmbH, Schöhnkirchen, Germany), and the femur was sequentially 
reamed 1-2 mm greater than the applied nail diameter. In 11/12 patients a T2 nail (Stryker) 
was used. In one patient a Groβe-Kempf nail (Stryker) was used. In three patients primary 
external fixation (Hoffman II, Stryker, Kalamazoo, Michigan) with secondary IMN (T2 nail) 
was performed. Cephalotine 2 g x 3-4 (Keflin®, 50 mg/ml, Lilly, Florence, Italy) was given 
intravenously as antibiotic prophylaxis according to the hospital routines.  
 
Blood sampling 
Hemoglobin (Hb) was measured in peripheral blood. Arterial- and mixed venous blood gas 
analyzes were collected according to Table 1. Serial blood samples were collected for 
determination of coagulation-, fibrinolytic-, complement- and cytokine activation in arterial 
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(sample time A-I) and mixed venous (sample time B-I) blood (Table 1). At sampling the first 
3 - 4 ml blood was always discarded. The samples were collected in Stabylite® (Biopool AB, 
Umeå, Sweden) tubes, and vacutainer tubes containing ethylenediaminetetraacetic acid 
(K2EDTA) or 1/10 vol 0.13M trisodium citrate. The tubes were gently turned, placed on ice 
and centrifuged within 30 minutes at 2000 g for 12 minutes at 4C. Plasma was aliquoted, 
transferred to 1.5 mL polypropylene tubes, and stored at -70° C until assayed. The samples 
were thawed only once. In the three patients who were initially externally fixated and 
subsequently nailed, blood samples were withdrawn related to both procedures. 
 
Assays 
Citrated plasma was used for the determination of thrombin-antithrombin-complexes (TAT) 
(Enzygnost TAT Micro, Behringwerke AG, Marburg, Germany, cat# OWMG15), 
plasminogen activator inhibitor (PAI-1) (TriniLIZE PAI-1 activity, Trinity Biotech, 
Jamestown, NY, USA, cat# T6004), tissue plasminogen activator (t-PA) antigen (TriniLIZE t-
PA antigen, Trinity Biotech, cat# T6001), soluble tissue factor (sTF) (Imubind TF Elisa, 
American Diagnostica Inc., Greenwich, CT, USA, cat# A845) and terminal SC5b-9 
complement complex (TCC) (by using an enzyme-linked immunosorbent assay (ELISA) as 
described by Mollnes et al.[19]).  Stabylite plasma was used for determination of t-PA activity 
(TriniLIZE t-PA activity, Trinity Biotech, cat# T6002). 
The following cytokines were analyzed in EDTA plasma by using commercially available 
ELISA kits; TNF-α (R&D Systems Europe, Abingdon, UK, Human TNF-α QuantiGlo 
Chemiluminescent Sandwich ELISA, sensitivity < 0.45 pg/mL, cat# QTA00), IL-6 (R&D, 
Human IL-6 QuantiGlo Chemiluminescent Sandwich ELISA, sensitivity 0.156 pg/mL, cat# 
Q6000B),  IL-1β (R&D, Human IL-1β QuantiGlo Chemiluminescent Sandwich ELISA,  
sensitivity < 0.4 pg/mL, cat# QLB00), IL-8 (R&D, Human CXCL8/IL-8 Quantikine 
Intramedullary nailing of femoral shaft fractures in polytraumatized patients      2011    
8 
 
colorimetric Sandwich ELISA, sensitivity 3.5 pg/mL, cat# D8000C) and IL-10 (R&D, Human 
IL-10 QuantiGlo Chemiluminescent Sandwich ELISA, sensitivity 1.58 pg/mL, cat# Q1000).  
 
Statistics 
Statistical analyzes were performed using the Statistical Package for Social Science (SPSS) 
software, version 16.0 (SPSS Inc, Chicago, IL, USA). Normally distributed data are presented 
as group means and standard error of the mean (S.E.M.). Paired-samples t-test was used for 
evaluation of increasing or decreasing levels between two measuring points. Non-parametric 
statistics were used when Kolmogorov-Smirnov test and histograms demonstrated not 
normally distributed data, as shown for RBCT, coagulation-, fibrinolysis- and cytokine 
activation. Median levels are then presented. Wilcoxon Signed Rank Test was used as the 
non-parametric test describing increasing and decreasing levels between two measuring 
points. Differences were considered significant at P levels ≤ 0.05. No statistics were 
performed, and no figures are presented related to the patients that were initially externally 
fixated and later nailed due to the small number of patients.  
 
Results  
12 patients were included, 11 men and 1 woman, aged 27.6 ± 2.5 (range 18-44) years. The 
mechanisms of injury were car accident (10/12) and fall from heights (2/12). ISS was 31 ± 
2.6, NISS was 34.3 ± 2.1, and AIS thorax was 3.7 ± 0.2. The time from injury to admission 
was 95 ± 11 (range 22 - 365) minutes. One patient had bilateral femoral shaft fractures. The 
fractures were classified according to AO; 3 A-fractures, 3 B-fractures and 7 C-type fractures. 
Two fractures were open (Gustilo Anderson 2 and 3A), and in 3 cases the fracture was openly 
reduced. All included patients had additional extremity- and thoracic injuries, 50% (6/12) 
abdominal, and 42% (5/12) had head injuries. The time from injury to femoral IMN was 544 
± 42 (range 330 – 830) minutes. The IMN operating time was 106 ± 7 (range 60 - 155) 
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minutes. Number of days in the intensive care unit (ICU) was 16 ± 4 (range 4 - 48). The 
postoperative course was prolonged by pneumonia (7/12), ALI (3/12), ARDS (3/12) and 
sepsis (3/12). All except one patient fulfilled the SIRS criteria. In the three patients who were 
initially externally fixated and secondarily nailed, the external fixation was performed 
822 (range 284 – 1582) minutes after the injury, and the operating time was 45 (range 34 – 
95) minutes. The time from injury to secondary IMN was between 6 and 10 days. In these 
patients mean ISS was 33 (range 29 – 34) and NISS 39 (range 34 – 43). 3/3 had pneumonia, 
2/3 ALI, 1/3 ARDS, 2/3 sepsis and 3/3 had SIRS. Number of days in the intensive care unit 
(ICU) was 12 ± 3 (range 9 - 19).  
 
None of the patients received blood product transfusions prior to hospital admission. 
Hemoglobin level at admission was 12.0 ± 0.7 and at skin incision 9.6 ± 0.4 g/100mL (p = 
0.015). The body core temperature at admission was 36.4 ± 0.3. The variation of 
administrated blood products was wide, and the majority of transfusions were given between 
hospital admission and the first day post IMN (Table 2).  
 
Coagulation and fibrinolysis 
In all patients a marked activation of the coagulation- and fibrinolytic systems was seen at 
hospital admission. Arterial TAT levels decreased during the study period, whereas arterial 
sTF levels increased. Arterial PAI-1 levels were high at admission and increased further until 
6 hours post procedure, the arterial t-PA activity levels were low at admission and stayed low 
during the study period, and the arterial t-PA antigen levels were high at admission and stayed 
elevated until decreasing from day one post IMN.  No significant differences were 
demonstrated between arterial and mixed venous blood levels for TAT, sTF, t-PA activity or 
PAI-1 (data not shown). 
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Coagulation  
Thrombin-antithrombin complexes (TAT) 
The arterial TAT (Fig. 2a) levels were highest at hospital admission and decreased from 
admission to the third postoperative day. The decrease was significant from admission to skin 
incision (p = 0.003), and from admission to the third postoperative day (p = 0.007). No 
increase of arterial TAT plasma concentration related to the IMN procedure was observed.  
 
 Soluble tissue factor (sTF) 
The arterial sTF (Fig. 2b) levels at admission were higher than normal levels and decreased 
from admission (A) to skin incision (B) (p = 0.045). A significant increase from nail insertion 
(C) to 72 hours (I) post nail insertion was found (p = 0.011). The highest sTF levels were 
present at the second and third postoperative day. No procedure-related effect could be 
detected.  
 
Fibrinolysis 
Tissue plasminogen activator (t-PA) activity and antigen 
Low arterial t-PA activity levels were demonstrated during the whole observation period, 
without any significant procedure-related increase of t-PA activity (data not shown). The t-PA 
antigen level (Fig. 2c) was increased at hospital admission compared with normal levels in 
healthy adults and remained elevated before decreasing from 24 – 48 hours post procedure. 
No significant increases or decreases related to IMN were seen. 
 
Plasminogen activator inhibitor-1 activity (PAI-1) 
The arterial PAI-1 activity (Fig. 2d) levels at admission were elevated when compared to 
normal levels in healthy adults and increased further significantly from admission (A) to skin 
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incision (B) (p = 0.001) and from nail insertion (C) to six hours (F) (p = 0.012). From six (F) 
to 48 hours (H1) post nail insertion (p = 0.005) the PAI-1 activity levels decreased. Peak PAI-
1 activity levels were demonstrated at skin incision (B) and at six hours post IMN (F). A 
procedure-related effect participating in the PAI-1 peak level response could not be ruled out.   
 
Coagulation and fibrinolysis in patients that were primary external fixated and secondary 
nailed 
The TAT, sTF and t-PA activity and antigen levels related to external fixation were similar to 
levels seen related to primary IMN. At secondary IMN a procedure-related increase of TAT, 
sTF and t-PA activity and antigen were present. 
After external fixation only minor changes of the PAI-1 activity levels were present. The 
levels were lower than after primary IMN.  Related to secondary IMN the PAI-1 response was 
almost absent.  
 
Complement activation 
Arterial TCC levels were studied in 6 patients. The TCC levels were slightly increased in 
most patients at admission and increased further (ns) from hospital admission (A) to the third 
postoperative day (I) (data not shown).  
 
Cytokines 
No significant differences were demonstrated between arterial and mixed venous blood levels 
for TNF-α, IL-6, IL-10, IL-1β, or IL-8.  
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TNF-α  
The arterial TNF-α level remained steady and almost at normal levels from hospital admission 
to six hours after IMN (F) and then increased significantly to the third post IMN day (I) (p = 
0.036) (Fig. 3a). The highest level was present the third post IMN day.  
 
IL-6 
Arterial IL-6 levels were elevated already at hospital admission, and for the whole study 
period the IL-6 levels exceeded 200 pg/mL. Peak levels were observed the third postoperative 
day (Fig. 3b). The increase from skin incision (B) to peak level at the third day post procedure 
was not significant (p = 0.39).   
 
IL-10 
Arterial IL-10 levels were elevated at hospital admission. A decrease from hospital admission 
to skin incision (p = 0.009) and a non-significant increase from skin incision to the first post 
IMN day (p = 0.28) was observed (Fig. 3c).  
 
IL-1β and IL-8 
IL-1β levels at all sampling locations were mostly below the lowest detectable level at 0.4 
pg/mL (data not shown). IL-8 levels demonstrated no significant increases or decreases within 
the study group (data not shown). 
 
Cytokine release in patients that were primary external fixated and secondary nailed 
Peak TNF-α levels were observed at 30 minutes (D) after external fixation and after 
secondary IMN. Peak IL-6 level was present after external fixation and secondary IMN at the 
second postoperative day, but was below 200 pg/mL on the third postoperative day. After 
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external fixation IL-10 peaked 30 minutes post procedure, whereas related to secondary IMN 
no peaks of IL-10 were present.  
 
Cardiopulmonary function  
The PAO2 – PaO2 difference (Fig. 4a) demonstrated elevated and further increasing levels (ns) 
from skin incision (B) to the third postoperative day (I). Procedure-related increased levels 
could not be demonstrated. Significantly decreasing SaO2 levels (Fig. 4b) from skin incision 
(B) to the third day post IMN (I) (p = 0.000) were observed. SvO2 (Fig. 4c) decreased 
significantly from skin incision (B) to two hours after IMN (E) (p = 0.046).     
 
CI ( Fig. 5a) increased significantly from skin incision (B) to the third postoperative day (I) (p 
= 0.000). MAP demonstrated no significant changes during the study period (data not shown). 
The SVRI (Fig. 5b) levels were lower than normal at skin incision and the levels, with the 
exception of a minor procedure-related (ns) increase, and continued to decrease (ns) during 
the study period. The changes in the filling pressures in the right (CVP) and the left (PCWP) 
side of the heart were modest, but with levels in the upper range of normal levels (data not 
shown). Both CVP and PCWP demonstrated peak levels at 30 minutes post IMN (D), the 
increases, however, were not significant. The MPAP (Fig. 5c) levels were high at skin 
incision (B), had a minor transient procedure-related increase, and increased further from the 
first (G1) to the third postoperative day (I) (ns, p = 0.07). The PVRI levels (Fig. 5d) were high 
at skin incision (B) and increased (ns, p = 0.057) further from skin incision (B) until peaking 
at 2 hours after the nail was inserted (E).  
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Cardiopulmonary function in patients operated with external fixation and secondary nailing 
PAO2 – PaO2 difference after external fixation demonstrated elevated and increasing levels 
from skin incision (B) to the first postoperative day (G1). Related to secondary nailing, the 
PAO2 – PaO2 difference was elevated at skin incision, and demonstrated decreasing levels 
during the study period. The SaO2 levels after external fixation and secondary nailing were 
decreasing from skin incision (B) to the third postoperative day (I). Minor increases of PVRI, 
MPAP and PCWP values were seen between 30 minutes and two hours after secondary IMN.  
 
Discussion    
In this study on 12 polytraumatized patients with femoral shaft fractures we investigated the 
impact of IMN on cardiopulmonary function and inflammation- and coagulation/fibrinolytic 
responses. The main observation was that an additional effect of the primary IMN, a second 
hit, on the activation of coagulation and fibrinolysis could not be clearly identified. A 
transient procedure-related PVRI increase was present. This may be a result of intravasation 
of intramedullary content. Delayed peak levels of arterial TNF-α, IL-6 and IL-10 levels were 
observed. In three patients the femoral shaft fractures were initially externally fixated and 
secondarily nailed. After external fixation the activation of coagulation and fibrinolysis were 
similar to the activation related to primary IMN, the cytokine activation was lower and 
dropped earlier, and on the first and second day post procedure the pulmonary shunting was 
elevated when compared to primary IMN. After secondary nailing a procedure-related 
coagulation- and fibrinolysis activation, and with lower levels than after primary IMN, was 
present. The secondary nailing resulted in a procedure-related cytokine response, but this 
response was prior to- and with lower levels than after primary IMN. Neither secondary nor 
primary IMN had a negative impact on pulmonary shunting. As observed after primary IMN, 
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a procedure-related effect on PVRI, MPAP and PCWP was observed between 30 minutes and 
two hours post IMN.  
 
In the present study systemic activation of the coagulation system, represented by arterial 
TAT level increase, was present at patient admission to the hospital. The high TAT levels 
were mainly related to the injury per se, and primary IMN did not result in additional TAT 
generation. Activation of fibrinolysis, measured as elevation of t-PA activity, was low. 
However, the t-PA antigen levels were high at hospital admission and stayed high before it 
dropped at 48 hours after IMN, which verify an increased fibrinolytic activity for much longer 
than the evaluation of t-PA activity alone suggests. The inhibition of the fibrinolysis, 
measured as augmented PAI-1 activity levels, was present at admission, and increased further.  
PAI-1 is produced upon stimulation by endothelial cells, platelets, fibroblasts and smooth 
muscle cells and functions as an acute phase reactant [20], and also binds circulating t-PA 
rapidly. Despite the prolonged increase in t-PA antigen levels, the functional effect of the 
PAI-1 increase (which is faster than other acute phase reactants like CRP and fibrinogen), 
combined with the nearly absent t-PA activity increase (neutralized by PAI-1) definitely 
represent a fibrinolytic shutdown and a prothrombotic state, which is often prevailing after 
orthopedic surgery or trauma. After external fixation, the activation of coagulation and 
fibrinolysis were similar to the activation observed after primary IMN. Related to secondary 
IMN, however, increased levels of both TAT and t-PA activities were measured.  
 
Tissue factor (TF) is the most potent trigger of the coagulation system known[21]. sTF is 
normally not present at measurable levels in the circulation[22]. Marked peaks of plasma TF 
activity have been demonstrated during bone preparation in total hip replacement surgery[23], 
which indicates release of TF-rich material to the systemic circulation from traumatized 
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tissues, mainly the bone marrow which is a rich source of TF. This mechanism may also 
explain the sTF levels found in the present study; elevated arterial sTF blood levels were 
demonstrated at hospital admission (A), which decreased slightly until skin incision (B) and 
then increased significantly until the third postoperative day (I), indicating an enduring 
procoagulant state. 
  
A significant cross-talk is present between coagulation, fibrinolysis, complement and 
inflammation[22, 24]. The complement cascade is activated by thrombin, and the complement 
split products stimulate TF synthesis in monocytes which in turn induces activation of the 
coagulation system[25]. The activation of the complement cascade occurs early (< 30 
minutes) after trauma[26, 27]. In the present study, and in accordance with the literature, 
elevated and further increasing TCC levels (ns) were observed. However, no procedure-
related increase of TCC levels was demonstrated, and the levels were lower than observed in 
the study by Fosse et al.[27] on severely injured patients. We have no good explanation for 
the difference between the present study and that of Fosse et al.[27], except that the ISS was 
lower (ISS 22, present study ISS 31) and the median time to hospital admission was 105 
minutes (present study 95 minutes). The time wise relation between injury and peak TCC 
levels was not described by Fosse et al.[27].  
Generation of proinflammatory cytokines has been demonstrated to be proportional to the 
extent of tissue injury and hypoxia[28-31]. TNF-α levels in our study were steady and slightly 
elevated until six hours post procedure (F) and were still increasing at day three post IMN. 
The still increasing levels at day three are not in agreement with other studies. Spielmann et 
al.[32] demonstrated the highest TNF-α level in trauma patients 12 hours post injury, with 
decreasing levels thereafter. Kobbe et al.[33] demonstrated no significant elevation of TNF-α. 
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Great variations in TNF-α levels (when measured) are observed in clinical studies, which can 
be explained by the short half-life of TNF-α[33]. 
  
The IL-6 levels in the present study were in general higher than 200 pg/mL, a level which is 
associated with SIRS[29]. In the one patient without SIRS, peak IL-6 level (at 6 hours post 
procedure) was 106 pg/mL. The elevated IL-6 levels in the present study were in agreement 
with other investigations demonstrating a post injury association between increased levels of 
IL-6, and high ISS and postoperative complications[28-31]. The IL-6 level peak in the present 
study occurred later than peak levels observed in other studies[8, 9, 28, 30, 34] in which IL-6 
peaked 4 - 24 hours post injury or post procedure and persisted for 3 - 10 days[30, 34]. 
Orthopedic surgery has in particular been associated with local release of IL-6[35]. Pape et 
al.[9] investigated patients with femoral shaft fractures and found venous IL-6 peak levels 24 
hours after IMN. When the femoral fracture was initially stabilized with external fixation and 
secondarily converted to an intramedullary implant, they did not, however, observe a surgery-
related IL-6 increase[9]. These results are inconsistent with the results in the present study 
demonstrating arterial IL-6 peak level at the second postoperative day after primary IMN and 
also a procedure-related IL-6 response after secondary IMN. The IL-6 levels after secondary 
nailing in our study were significantly lower than the levels after primary IMN. The results 
from the study of Pape et al.[9] were also inconsistent with the results from the study of 
Morley et al.[36] in which blood samples from the femoral canal before and after reaming of 
the canal showed very high levels of IL-6 after intramedullary reaming (median 3947 at 
opening and 15903 pg/mL after reaming). These very high levels indicated a significant local 
inflammatory reaction following the dual trauma (fracture and IMN). Due to intravasation and 
pulmonal sequestering of bone marrow content at intramedullary pressure increase during 
femoral canal reaming, an additional pulmonary IL-6 activation has been suggested in an 
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experimental porcine study[37]. Levels of IL-6 in both mixed venous and arterial blood were 
analyzed in the present study, but the results did not confirm the suggestion.  
 
No IL-1β or IL-8 response was observed in the present study. This is consistent with other 
studies[33, 37, 38].  
 
For the evaluation of the anti-inflammatory response IL-10 was studied. In the present study, 
related to primary IMN, IL-10 levels were elevated during the study period, and peak IL-10 
level was observed at the first day  post primary IMN. This IL-10 response was delayed 
compared to other studies demonstrating an IL-10 response after 1 - 6 hours post injury[33, 
39]. 
 
In the literature, there is no uniform understanding of the effect of IMN on hemodynamics 
and pulmonary function. Early operative fracture treatment, especially of large long bones 
(femur), has empirically been associated with reduction in the occurrence of pulmonary 
failure (ARDS)[40-42]. However, some data also indicate that the early internal stabilization 
of these fracturesin itself can have negative impacts on pulmonary function. The total effect of 
IMN on morbidity seems, however, to be beneficial.  
 
The reported incidences of ALI and ARDS in severely injured patients with femoral shaft 
fractures are not uniform[42-44]; a higher incidence is suggested if the fractures are 
accompanied by thoracic injuries[43]. In the present study 6/12 patients had ALI or ARDS 
(3/12 ALI and 3/12 ARDS).  The pathophysiology of the early ALI after trauma is fluid 
leakage and pulmonary edema combined with inflammatory cell infiltration of pulmonary 
tissue. In addition, a hypoxemic vasoconstriction and capillary microthrombosis creates a 
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ventilation-perfusion mismatch, clinically manifested as hypoxemia. The PAO2 - PaO2 
difference increased in the severely injured patients in this study as a surrogate indicator for 
increased pulmonary shunting.  Pulmonary vascular changes may cause an increased 
pulmonary vascular resistance and increase the MPAP[45]. In the present study MPAP was 
elevated already at skin incision, and demonstrated a minor procedure-related increase, before 
continuously increasing towards the end of the study period. Simultaneously, a procedure–
related PVRI level increase was observed. In previous human studies increased MPAP, PVR 
and CVP  plus decreased PaO2  have been associated with pulmonary embolism[46].  These 
associations, however, have to be interpreted carefully as pressure increases in previous 
normal, easily distendable, pulmonary blood vessels may retain undetectable until at least 
30% of the vessels are occluded[47]. In pre-injured lungs the effect of compensatory 
dilatation will not occur equivalently, and the flow in the still open pulmonary vessels will 
increase and create significantly elevated PVR levels. The filling pressures of the heart, CVP 
and PCWP, are influenced by treatment, quantum of intravenous fluid/blood administration 
and the titration of ventilator volumes, pressures and rates. As strict control of these 
parameters is impossible in a clinical setting, CVP and PCWP are not suitable for the 
evaluation of impact of surgical interventions on cardiac function. 
 
Polytraumatized patients usually consist of a heterogeneous group of patients, and firm 
conclusions from clinical studies are difficult to draw. Differences in the extent of injury, time 
from injury to hospital admission, time from admission to operation, extent of further 
operations and amount of blood product transfusions induce a wide range of variance. The 
included patients in the present study were extensively examined, which also made the patient 
inclusion and follow-up challenging. The present patient material consisted of patients with 
high ISS, femoral shaft fractures equally treated, and all registrations, calculations and 
analyzes were strictly related to IMN.  However, the included patients were relatively few. 
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We did not differentiate and relate the observations and calculations to specific organ system 
injuries. For such differentiation, larger studies and multi-centre trials are needed.  
 
Conclusions 
In the severely injured patients with femoral shaft fractures operated with primary IMN we 
observed a substantial response related to the initial trauma. We could not demonstrate any 
major additional IMN-related impact on theinflammation or the cardiopulmonary function 
parameters. A transient cardiopulmonary response related to IMN, however, was 
demonstrated. Delayed arterial TNF-α, IL-6 and IL10 peak levels were observed, and it could 
be questioned whether these were related to the procedure. The inflammation-associated 
complication rate was high.   
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 Figure legends 
 
Figure 1. Flow chart of patients admitted with femoral shaft fracture and included in the 
study.  
 
Figure 2. The figure shows the arterial TAT (2a), sTF (2b), t-PA antigen (2c) and PAI-1 
activity (2d) (median and 25/75 percentiles) at admission (A), skin incision (B), after nail 
insertion (C) and 30 minutes (D), two (E) and six (F) hours, the first (G1), second (H1) and 
third (I) day after the nail insertion in the patients primarily nailed.  
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Figure 3. The figure shows the arterial TNF-α (3a), IL-6 (3b) and IL-10 (3c) (median and 
25/75 percentiles) at admission (A), skin incision (B), after nail insertion (C) and 30 minutes 
(D), two (E) and six (F) hours, the first (G1), second (H1) and third (I) day after the nail 
insertion in the patients primarily nailed.  
 
Figure 4. The figure shows PAO2 –PaO2 difference (Fig. 4a), SaO2 (Fig. 4b) and SvO2 (Fig. 
4c) (mean ± S.E.M.) at skin incision (B), after nail insertion (C) and 30 minutes (D), two (E) 
and six (F) hours, the first (G1 and G2), second (H1 and H2) and third (I) day after nail 
insertion in the patients primary nailed.  
 
Figure 5. The figure shows the time course (mean ± S. E. M.) for CI (Fig. 5a), SVRI (Fig. 5b), 
MPAP (Fig. 5c) and PVRI (Fig. 5d) at admission (A), skin incision (B), after nail insertion 
(C) and 30 minutes (D), two (E) and six (F) hours, the first- (G1 and G2), second- (H1 and 
H2) and third (I) day after primary IMN.  
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Tables 
 
Table 1. Time schedule for analysis, registrations and calculations 
Time Surgical procedure Blood sample analyses  Cardiopulmonary 
registrations and 
calculations 
A Hospital admission Blood gases, Hb, cytokines, coagulation, 
fibrinolysis, complement 
 
B Skin incision Blood gases, Hb, cytokines, coagulation, 
fibrinolysis, complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
C After nail insertion Blood gases, coagulation, fibrinolysis, 
complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference  
D 30 minutes after nail insertion Blood gases, cytokines, coagulation, 
fibrinolysis, complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
E 2 hours after nail insertion Blood gases, Hb, cytokines, coagulation, 
fibrinolysis, complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
F 6 hours after nail insertion Blood gases, Hb, cytokines, coagulation, 
fibrinolysis, complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
G1 1. postoperative day at 0800  Blood gases, Hb, cytokines, coagulation, 
fibrinolysis, complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
G2 1. postoperative day at 1800  Blood gases CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
H1 2. postoperative day at 0800  Blood gases, Hb, cytokines, coagulation, 
fibrinolysis, complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
H2 2. postoperative day at 1800 Blood gases CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
I 3. postoperative day at 0800 Blood gases, Hb, cytokines, coagulation, 
fibrinolysis, complement 
CI, SVRI, PVRI, HR, 
MAP, CVP, MPAP, 
PCWP, SvO2, PAO2-PaO2 
difference 
Table 1. The table shows the time schedule for blood sampling and cardiopulmonary 
registrations and calculations at hospital admission (A), skin incision (B), after insertion of the 
nail (C), and at 30 minutes (D), two (E) and six (F) hours after nailing, and at 0800 (G1) and 
1800 hour (G2) the first-, 0800 (H1) and 1800 hour (H2) the second- and at 0800 (I) hour the 
third postoperative day.  
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Table. 2. Blood product transfusions  
Time RBCT TT PT 
Admission - IMN (A-B) 900 (0-4800) 0 (0-500) 0 (0-400) 
IMN - 6 hours post IMN (B-F) 750 (0-2100) 0 (0-500) 0 (0-400) 
Admission - 1. postoperative day (A-G1) 2250 (0-6900) 0 (0-1000) 0 (0-1400) 
1. - 2. postoperative day (G1 - H1) 600 (0-1500) 0 (0) 0 (0-400) 
2. - 3. postoperative day (H1 - I) 300 (0-600) 0 (0-500) 0 (0-400) 
TOTAL 3000 (0-8100) 0 (0-1500) 200 (0-1400) 
Table 2. The table gives a summary of administrated red blood cell transfusion (RBCT), 
thrombocyte transfusion (TT), blood plasma transfusion (PT) in milliliter (median and range) 
from hospital admission to intramedullary nailing (IMN), from IMN to 6 hours after IMN, 
from hospital admission to the first postoperative day, from the first to the second 
postoperative day, from the second to the third postoperative day and total transfusions in the 
patients primary nailed.    
 
 

